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ABSTRACT 
The mucosal barrier of the small intestine is highly dynamic, enabling the 
passage of nutrients that are necessary for the body’s function while 
simultaneously preventing a breach by harmful microorganisms that are 
damaging to the host.  The effectiveness of the mucosal barrier is dependent on 
the cohesive relationship established between the luminal mucosal epithelium 
and the underlying immune compartment in the small intestine.  The epithelium 
provides the first line of defense against pathogens by establishing a physical 
barrier separating the external environment from the body’s internal milieu, while 
the immune system secondarily responds to clear bacteria that have breached 
the epithelial barrier.  The HECT E3 ubiquitin ligase ITCH is known to regulate 
immune responses, and loss of function of ITCH has been associated with 
gastrointestinal inflammatory disorders.  However, the high level of ITCH 
expression within the intestinal epithelium suggests that it may have an important 
function(s) in that tissue for maintaining gut homeostasis.  Indeed, we identified 
that global loss of ITCH (Itcha18H/a18H) in young adult animals influenced intestinal 
architecture characterized by increases in both crypt and villus area that were 
more prominent in the distal part of the small intestine.  Increased crypt area was 
found to result from expansion of both the proliferating transit amplifying   
progenitor population and terminally differentiated Paneth cells.  Lack of ITCH 
also resulted in changes in numbers of goblet cells on the villus.  Epithelial cell
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turnover was also accelerated in Itcha18h/a18H animals, as evidenced by increases 
in both proliferation and apoptosis within the crypt, as well a more rapid cell 
migration of bromodeoxyuridine-labeled epithelial cells along the crypt-villus axis.  
Consistent with the observed enhancement of cellular migration, Itcha18H/a18H 
mice carrying the Min mutation (Itcha18H/a18H; ApcMin/+) displayed a 76% reduction 
in tumor burden as compared to ApcMin/+ littermates with normal levels of ITCH. 
To identify which aspects of these changes were cell autonomous, intestinal 
organoids were generated from the crypts of ITCH sufficient and ITCH deficient 
animals. Interestingly, epithelial cell proliferation and differentiation were not 
perturbed in ITCH deficient organoids, in contrast to the in vivo phenotype of the 
Itcha18H/a18H small intestines.  However, increased cell death was observed in 
organoids lacking ITCH, which was also consistent with increased cleaved-
caspase 3 staining in the intestines of mice lacking ITCH exclusively in the 
intestinal epithelium.  The failure to recapitulate the Itcha18H/a18H epithelial 
phenotype prompted us to investigate how loss of ITCH in immune cells impacts 
the intestinal epithelium.  Animals lacking ITCH within the myeloid cell lineage 
have similar defects in crypt area, as well as increases goblet and Paneth cell 
numbers, as compared to the Itcha18H/a18H animals, albeit delayed.  These finding 
highlight a cell autonomous as well as non-cell autonomous function for ITCH in 
mediating epithelial homeostasis, and emphasize the importance of ITCH in 
small intestinal barrier function.
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 Throughout an organism’s life span, many tissues are in a constant state 
of flux, varying their cellular composition and function to reflect the internal and 
external stimuli that are present at that particular time.  While tissues must vary 
their internal steady state to appropriately respond to the current environmental 
cues, if changes deviate outside of a tissue’s predefined, normal steady state 
range, its integrity can be compromised.  To prevent major shifts in cell 
composition and function from occurring, tissue homeostasis is essential.  This 
homeostatic process is dependent on cell turnover, or the balanced regulation of 
cell death with cell proliferation.  As cells become “worn out” or damaged over 
time, these functionally insufficient cells must be replaced with functionally 
competent cell types that will preserve the tissue’s integrity.  Regulation of this 
process is initiated by somatic stem cells that reside within a given tissue.  
Somatic stem cells are multipotent cells that are defined by their unlimited self-
renewal properties as well by their ability to differentiate into all major cell types 
within a given tissue.  When a somatic stem cell asymmetrically divides to 
produce two daughter cells with different cell fates, one cell will typically retain 
the unlimited self-renewal properties of the parental cell, while the other cell 
adopts a progenitor cell fate.  Progenitor cells, which exhibit limited self-renewal 
capabilities, will continue to divide, and, when exposed to the appropriate signals,
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will terminally differentiate into all the cell types that comprise a particular tissue.  
Once terminally differentiated cells are generated, these cells must be able to 
integrate into the tissue to replace the cell that was lost.  If a breakdown in any 
component of this highly integrated process does occur, this can have 
catastrophic impacts on tissue homeostasis and promote pathologies ranging 
from neurological disorders to cancer.   
Homeostasis within the small intestine is essential to digestion, nutrient 
absorption, and water balance.  These processes are mainly dependent on the 
epithelium that lines the luminal cavity to separate the external environment from 
the internal milieu.  The epithelium consists of a single layer of columnar cells 
that fold into long, finger-like structures, commonly referred to as villi, which 
protrude out into the lumen, and deep invaginations into the underlying 
submucosa known as the crypts of Lieberkühn (Fig.1.1).  Within the small 
intestinal crypts, the rapidly dividing, multipotent crypt base columnar (CBC) stem 
cell population resides at the base of the crypt interspersed between the Paneth 
cells (van der Flier and Clevers, 2009).  An additional slowly-dividing, reserve 
stem cell population also exists in the +4 (cell population located directly above 
the Paneth cell population) of the small intestinal crypt.  During obligate 
asymmetrical cell divisions, intestinal stem cells will produce a single intestinal 
stem cell to replenish the existing pool of stem cells, as well as give rise to a 
progenitor cell, defined as being equivalent to a transit-amplifying (TA) cell, that 
is capable of terminally differentiating into one of the five major cell types of the 
small intestine (Barker, 2013).  
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Terminally differentiated intestinal epithelial cells arise from the highly 
proliferative TA cells that are generated during cellular division of the CBC stem 
cell population.  As TA cells migrate along the crypt-villus axis, dividing 
approximately five-to-six times, they eventually specify into the five major 
epithelial cell types of the small intestinal epithlium (Potten, 1998).  The function 
of these five cell types is dependent upon the lineage from which they are 
derived.  Enterocytes originate from the absorptive cell lineage and are the most 
abundant cell type in the small intestine.  They comprise approximately 75-80% 
of the total post-mitotic cells that are produced and are critical to nutrient 
absorption (van der Flier and Clevers, 2009).  The secretory cell lineage is 
comprised of the remaining four major cells types: enteroendocrine, goblet, tuft, 
and Paneth cells (Barker, 2013).	 The enteroendocrine cells, located along the 
villi, produce and secrete hormones that are critical to physiological and 
homeostatic functions of the small intestine (Moran et al., 2008).  Tuft cells, or 
brush cells, are also located on the villi and are hypothesized to play a role in 
chemosensitivity.  However, emerging evidence suggests that they are also 
critical mediators of host defense during enteric infection and inflammation 
(Steele et al., 2016).  Goblet cells provide a protective shield for the intestines 
through the secretion of mucin. Paneth cells reside in the crypt interposed 
between the CBC stem cells and contribute to the stem cell niche while 
concurrently protecting the small intestine by secreting antimicrobial agents 
against foreign microbes.  
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 Epithelial self-renewal in the small intestine is very rapid, occurring 
approximately every four-to-five days (Barker, 2013). To maintain intestinal 
homeostasis throughout this rapid process, aged cells must be expeditiously 
replaced with newly differentiated cells that arise from the proliferative crypts 
(Nunes et al., 2014).  Proliferation within the small intestinal crypt of mice has 
been established as the principle force governing homeostatic cell migration 
(Parker et al., 2017).  Reduction or temporary suspension of proliferation in the 
crypts of mice directly influences cell migration velocities onto the villi.  
Preservation of proliferation and migration is critical to epithelial homeostasis, 
and dysregulation of these processes can promote a range of gastrointestinal 
pathologies (Fre et al., 2009; Hanahan et al., 2000; Roda et al., 2010).  
Cellular adhesion complexes between adjacent small intestinal epithelial 
cells can also influence cell migration.  Tight junctions, adherens junctions, and 
desmosomes line the lateral membranes of intestinal epithelial cells to ensure 
cell adhesion and polarity while concurrently preventing the entrance of luminal 
pathogens (Garcia et al., 2017).  Tight junctions, located near the apical surface 
of the cells, prevent the passage of unwanted substrates from the luminal 
environment across the epithelium.  Adherens junctions are located directly 
below tight junctions, and, in combination with tight junctions, they constitute an 
apical junctional complex that is directly attached to the actin cytoskeleton of the 
cell.  Additional intracellular adhesion is provided by desmosomes, which are 
located directly under adherens junctions. 
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Adherens junctions are composed of the transmembrane glycoprotein E-
cadherin that forms homophilic interactions with adjacent cells to mediate cellular 
adhesion as well as cell signaling (Bondow et al., 2012; Etienne-Manneville, 
2012).  To ensure cellular adhesion, E-cadherin proteins are attached to the 
catenin family of proteins (β-catenin, p120, and plakoglobin), which secures the 
entire junctional complex to the actin cytoskeleton of the cell via its association 
with α-catenin (Hartsock and Nelson, 2008).  The epithelial-specific loss of E-
cadherin in the adult intestine enhances cellular migration along the crypt-villus 
axis (Schneider et al., 2010).  Further, disruption of cadherins in mice mediated 
by overexpression of dominant-negative N-cadherin under the Fabp1 promoter 
resulted in accelerated migration (Hermiston et al., 1996).  In contrast to loss of 
E-cadherin, forced expression of E-cadherin in the intestinal epithelium of mice 
slowed cellular migration along the crypt-villus axis (Hermiston et al., 1996). 
As terminally differentiated cells migrate along the crypt-villus axis, they 
eventually reach the tip of the villus and are sloughed off into the luminal cavity. 
In the small intestine, this process is continuous and results in nearly 1,400 cells 
from a single villus being shed into the luminal cavity each day (Potten, 1990; J. 
M. Williams et al., 2015).  A particular type of apoptosis, termed anoikis, 
mediates cell extrusion from the villus tip of the intestinal epithelium (Delgado et 
al., 2016).  Detachment of a cell from the underlying extracellular matrix activates 
anoikis either through mitochondrial dysfunction (intrinisic) or cell death receptors 
(extrinsic) and converges on caspase 3 before the cell undergoes demise (Paoli 
et al., 2013).  To ensure that the intestinal barrier is still maintained throughout 
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anoikis, both apoptotic cells as well as the neighboring cells redistributes tight 
junctions to their basolateral membrane (Guan et al., 2011; Marchiando et al., 
2011).  The surrounding cells then extend cytoplasmic processes underneath the 
apoptotic cells before the cell is extruded from the epithelium to ensure that tight 
junctions are able to reform instantaneously to prevent the passage of bacteria 
(J. M. Williams et al., 2015).  
As a dividing line between the internal and external compartments, the 
epithelium also plays an indispensable role in preventing the entry of foreign 
substrates (Bischoff et al., 2014).  The epithelium of the small intestine is 
generally regarded as the “first line of defense”, hindering the penetration of 
bacteria into the internal environment of the host (Peterson and Artis, 2014).  
This mainstay barrier is typically an effective deterrent, however, the constant 
exposure of noxious substances, antigens, and microorganisms to the surface of 
the epithelium along the gastrointestinal tract makes a breach of foreign material 
eventually inevitable (Schenk and Mueller, 2008).  During this event, the 
underlying immune compartment which coexists with the mucosal epithelium 
initiates an inflammatory response to contain and destroy the non-native 
substrate while concurrently attempting to ameliorate the defective epithelial 
barrier by influencing epithelial homeostasis.  Since the integrity of the mucosa is 
consistently being challenged, synergy between these two compartments is 
paramount in providing an adequate level of protection against the external 
environment.  If a breakdown in any component of this highly integrated mucosal 
system does occur, this can have catastrophic impacts on mucosal homeostasis, 
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promoting a wide-range of gastrointestinal enteropathies (Catalioto et al., 2011; 
Huang and Chen, 2016; Maloy and Powrie, 2011; Nunes et al., 2014).  
The subepithelial immune compartment of the intestinal mucosa resides in 
the lamina propria, a layer of loose connective tissue that is rich in immune cells 
that reside in parallel with an extensive vascular network, lymphatic vessels, 
extracellular matrix proteins, and the mesenchyme.  Immune cells are in close 
proximity to the intestinal epithelium and support the intestinal epithelial barrier 
by initiating a targeted response toward a pathogenic substrate that has 
circumvented the epithelial mucosal barrier (Okumura and Takeda, 2016). 
Intestinal immunity is orchestrated by a heterogonous population of immune cell 
types, derived from both the myeloid and lymphoid cell lineages, that are present 
in the lamina propria.  Dendritic cells (DCs), macrophages, and intraepithelial 
lymphocytes are in direct contact with the epithelium and immediately respond to 
antigenic material that has permeated the epithelial barrier, while regulatory T-
cells (Treg) cells in the subepithelial immune compartment precisely regulate the 
inflammatory response and prevent hyper-activation of the immune system to the 
pathogen (Okumura and Takeda, 2016).  Lastly, naïve CD4+ T-cells present 
within the lamina propria differentiate into either memory or effector T cells in 
response to a bacterial substrate and exhibit rapid and potent cytotoxic activity if 
the same substrate is encountered subsequently.  The cell types work in unison 
to regulate intestinal immunity by mounting an appropriate inflammatory 
response to clear pathogenic material while simultaneously exhibiting tolerance 
to macromolecules and to the host’s microbiota (Vindigni et al., 2016). 
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 The innate immune system contributes to mucosal function and 
homeostasis by continuously surveying the gut’s microbiotic landscape (Gross et 
al., 2015).  Harmful and innocuous bacteria that have breached the epithelium 
are first identified by macrophages and DCs that reside in close proximity to the 
epithelium, and, as such, mediate immune tolerance within the intestine.  Derived 
from a common myeloid progenitor in the bone-marrow, macrophages and DCs 
exhibit overlapping functions, but also display unique properties that are specific 
to each cell type.  Traditionally, macrophages and DCs are both potent antigen-
presenting cells, presenting antigens from ingested pathogens for recognition by 
T-cells to induce acquired immunity (Geissmann et al., 2010).  While a potent 
inflammatory response is typically initiated by this interaction, resident intestinal 
macrophages and DCs have adapted to enteric commensal bacteria by 
dampening the inflammatory response to promote immune tolerance over 
inflammation (Bain and Mowat, 2014; Smythies et al., 2005).    
  Macrophages are dispersed throughout the lamina propria of the gut and 
are strategically placed to intercept invading microorganisms (Schenk and 
Mueller, 2008).  Bacteria that have penetrated the epithelial barrier are 
phagocytosed and destroyed by macrophages to effectively clear the bacteria. 
Unlike monocytes and macrophages from other tissues, intestinal macrophages 
respond differently to pathogenic substrates and effectively expunge the bacteria 
without inducing a potent inflammatory response (Macpherson and Harris, 2004; 
Schenk and Mueller, 2008).  Binding of the bacteria to toll-like receptors or 
intracellular NOD receptors does not cause the secretion of proinflammatory 
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cytokines, such as TNF (Tumor necrosis factor)-α , IL (Interleukin)-1, or IL-6 
(Bain and Mowat, 2014; Smythies et al., 2005).  However, intestinal 
macrophages constitutively secrete IL-10, and low amounts of TNF-α, to 
contribute to intestinal homeostasis and barrier function (Gross et al., 2015).  IL-
10 is an anti-inflammatory cytokine that mediates intestinal tolerance to bacteria 
by inhibiting pro-inflammatory cytokine secretion from macrophages and T-cell 
inflammatory responses, as well as modulating Treg (Mantovani and Marchesi, 
2014).  Consistent with this assertion, IL-10 deficient mice develop spontaneous 
colitis characterized by hyperproliferation of the epithelium and hyperactivation of 
the immune system in response to commensal bacteria (Kühn et al., 1993).  
DCs are specialized cells that can effectively communicating with T-cells 
to induce their activation and differentiation (Stockwin et al., 2000).  Similar to 
macrophages, they are located in close proximity to the epithelium, which allows 
them to expeditiously detect pathogenic bacteria that have gained entry into the 
host.  Upon bacterial ingestion, DCs will migrate to other secondary lymphoid 
tissues to partner with naïve CD4+ T-cells and induce T-cell polarization into 
effector cells that will propagate an inflammatory response (Gross et al., 2015).  
In the small intestine, DCs also display signs of tolerogenicity.  DCs that are 
present in mesentery lymph nodes and in the lamina propria secrete retinoic acid 
and transforming growth factor (TGF)-β to promote the generation of Treg, which 
increase the inhibitory function of other immune cell types to reign in 
inflammation (Okumura and Takeda, 2016; Sun et al., 2007). 
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 The chronic, low-grade inflammatory state within the small intestine is 
delicately balanced by the regulatory action of Treg and pro-inflammatory T-
helper (Th) 17 cells within the lamina propria (Omenetti and Pizarro, 2015).  Treg 
and Th17 cells both derive from naïve T-cells that are exposed to the key 
mediator TGF-β, but have distinctly opposite biological functions in the immune 
system (Eisenstein and Williams, 2009).  While Treg potently suppress the 
function of other immune cells by secreting inhibitory cytokines, such as IL-10, 
TGF-β, and IL-35, that limit the activation and differentiation of immune cells, 
Th17 cells promote a robust inflammatory response to the local microbiota, 
which, if not restrained, will results in pathogenic inflammation (Omenetti and 
Pizarro, 2015).  In the small intestine, the secretion of these key mediators by 
innate immune cells is critical for establishing a balance between Treg and Th17 
to promote an environment that is tolerant to the microbiota.  Retinoic acid, which 
is produced by DCs in the lamina propria, promotes T-cell specification toward 
the Treg lineage, while IL-6 and the transcription factor ROR-λt, promote Th17 
development (Mucida et al., 2007).  Intestinal macrophages further contribute to 
Treg specification by failing to secrete IL-6 upon pathogen binding.  If this 
balance becomes disrupted, this can promote an inflammatory state that is 
difficult to restrain.  
 The pro-inflammatory Th17 cell type normally resides in the lamina propria 
of the small intestine during homeostatic conditions to mediate host defense 
extracellular bacteria and fungi that have penetrated the barrier.  Secretion of the 
cytokine IL-23 from macrophages and dendritic cells activates Th17 cells to 
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mount an immune response to pathogenic substrates by secreting the cytokines 
IL-17, IL-21, and IL-22 (Symons et al., 2012).  However, if IL-23-mediated 
activation of Th17 cells is not precisely regulated, their protective function can 
become pathological, as is seen in a spectrum of autoimmune diseases 
(Langrish et al., 2005; Omenetti and Pizarro, 2015).  The transcription factor 
ROR-λt induces the secretion of IL-17, an indispensible component of Th17 
mediated inflammation.  Thus, understanding the regulation of ROR-λt in IL-17-
mediated colitis is of therapeutic interest.   
The highly variable environment within the lumen consistently challenges 
the mucosal barrier of the small intestine.  In response to this continual flux, 
specific and rapid changes within the cellular architecture of the mucosa must 
occur to promote barrier integrity and function (Pastorelli et al., 2013).  Post-
translational modifications, such as ubiquitylation, regulate cellular responses to 
generate appropriate signals by influencing the stability, localization, or function 
of a protein substrate (Rotin and Kumar, 2009).  Attachment of ubiquitin to a 
target protein requires the sequential action of the E1 ubiquitin activating 
enzyme, the E2 ubiquitin conjugating enzyme, and the E3 ubiquitin ligase, the 
latter of which confers substrate specificity (Popovic et al., 2014).  Activation of 
ubiquitin, a 76 amino-acid polypeptide, is an ATP dependent process that is 
initiated by the E1 enzyme and allows the carboxy terminus of ubiquitin to attach 
to an active cysteine residue on the E1 via a thioester bond (Metzger et al., 
2012).  The activated ubiquitin is transferred to one of nearly 40 E2s, forming a 
similar thioester linkage with a cysteine residue on the E2.  The E3 ligase-protein 
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complex partners with an ubiquitin-primed E2 enzyme to transfer the ubiquitin to 
an ε-amino group of a lysine residue on the protein target (Rotin and Kumar, 
2009).  With over 600 E3 ligases present within the mammalian genomes, the 
diverse repertoire of protein substrates that are targeted for ubiquitylation is 
dependent on the E3 ligase (Li et al., 2008).  Two major families of E3 ligases 
have been identified: the really-interesting new gene (RING)-family and the 
homeologous to the E6AP carboxyl terminus (HECT)-family (Metzger et al., 
2012).  The catalytic action of the HECT-family of E3 ligases allows ubiquitin to 
be transferred to a cysteine residue within the HECT domain before being 
directly attached to the protein target.  Unlike HECT E3 ligases, the RING-family 
does not have catalytic action to accept and transfer ubiquitin to their target 
proteins, rather serves as linkers to place the substrate and E2 in close proximity 
to facilitate ubiquitylation.  
The HECT domain present within this E3 ligase family is positioned at the 
C-terminus of the protein, providing a protein-binding motif for the E2 enzyme to 
bind to as well as a critical cysteine residue to transfer the activated ubiquitin 
(Bernassola et al., 2008).  Within this family, the E3 ligases are further classified 
into 3 subclasses based on their protein-protein binding domains that allow the 
E3 ligase and protein target to interact.  Of the three, the Nedd4-like family of E3 
ligases has been the best characterized.  The structure of the 9 mammalian 
family members consists of a N-terminal C2 domain capable of binding Ca2+ and 
phospholipids, two to four tryptophan-tryptophan (WW) protein interacting 
domains, and a catalytic C-terminal HECT domain (Chen and Matesic, 2007).  
	 13	
The WW domains of HECT E3 ligases confer substrate specificity and show 
preferential binding to PPXY motifs present within proteins.  
The HECT E3 ligase ITCH was first identified from a radiation- and 5-
hydroxyurea- induced paracentric inversion on the distal end of mouse 
chromosome 2, which disrupted both the Agouti and Itch loci (W L Perry et al., 
1998).  Animals homozygous for this loss of function mutation (Itcha18H/a18H) 
developed a spontaneous and progressive, late-onset autoimmune-like 
phenotype that was lethal by 6-8 months of age (C M Hustad et al., 1995).  On a 
C57BL/6J background, Itcha18H/a18H displayed lymphoproliferaton in the spleen, 
lymph nodes, and thymus, atopic dermatitis, and pulmonary interstitial 
inflammation, the latter of which culminated in animal mortality.  The 
inappropriate activation of the immune system at the mucosal surfaces of the 
skin and lung of ITCH deficient animals was attributed to a decrease in ITCH-
mediated ubiquitylation of JunB, a transcription factor that drives Th2 polarization 
(Fang et al., 2002a).  Interestingly, the autoimmune-like phenotype associated 
with loss of ITCH function in mice phenotypically recapitulates ITCH deficiency in 
humans.  The multisystem autoimmune syndrome that humans displayed as a 
consequence of a truncating mutation of ITCH is characterized by organomegaly, 
failure to thrive, and autoimmune infiltration within the lungs, liver, and the 
gastrointestinal tract (Lohr et al., 2010).  Further characterization of the 
homozygous null a18H mutation of Itch mice also identified an inflammatory 
phenotype within the mucosa of the gut (Kathania et al., 2016).  Animals deficient 
for ITCH developed spontaneous colitis at 6-8 months of age that was 
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characterized by mixed inflammatory infiltrate present within that colon as well as 
deterioration of the colonic epithelium.  The development of colitis within the 
Itcha18H/a18H animals was attributed to an increase in IL-17 produced from Th17 
helper T-cells, innate lymphoid cells, and λδ T-cells, which was driven by 
decreased ITCH-mediated ubiquitylation of ROR-λt.   
In addition to the inflammation that is present in the colon of Itcha18H/a18H 
animals, mild inflammation is also observed along the small intestinal tract in 5-7 
month old Itcha18H/a18H animals.  While a role for ITCH in the small intestine has 
yet to be defined, the mild inflammation is that is present in this organ suggests 
that loss of ITCH function influences small intestinal homeostasis. Consistent 
with this assertion, ITCH expression is relatively high within the normal 
epithelium of the small intestine in humans as compared to other tissue types, 
and its expression is increased in colorectal cancers that develop along an 
adenoma-to-carcinoma sequence.  Further support for ITCH’s role in the small 
intestinal homeostasis is evident from the numerous transcription factors, 
receptors, and signaling transducers that are identified as targets of ITCH that 
are reviewed below, and also play a signficant role within the small intestinal 
mucosa (Table 1.1).   
Accumulating evidence supports a regulatory function for the E3 ligase 
ITCH within embryonic (ESC) (Liao et al., 2013), somatic (Rathinam et al., 2011), 
and cancerous stem cells (Tsui et al., 2017).  In ESC, ITCH maintains stemness 
by directly interacting with and ubiquitylating OCT4, a transcription factor that 
induces pluripotency, to increase its transcriptional activity and stability (Liao et 
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al., 2013).  Further, loss of ITCH reduced the self-renewal capacity of ESC and 
reduced a somatic cell’s ability to be reprogrammed into pluripotent stem cells.  
ITCH also promotes cancer cell stemness in the hepatocellular carcinoma (HCC) 
cell line Huh-7 by targeting and degrading the phosphorylated form of 
Dishevelled-3 (DVL3) (Tsui et al., 2017).  Within HCC, two forms of DVL3 exist: 
phosphorylated DVL3 and a non-phosphorylated DVL3, the latter of which 
promotes cancer cell stemness.  Disruption of this balance can be achieved by 
ITCH-mediated ubiquitylation of phosphorylated DVL3, which increases the 
amount of non-phosphorylated DVL3 as compared to phosphorylated DVL3.  
Non-phosphorylated DVL3 promotes cancer stem renewal in HCC by increasing 
B-catenin transcriptional activity and increasing LGR5 mRNA levels.  In contrast, 
the hematopoetic stem cell (HSC) pool, self-renewal is negatively regulated by 
ITCH (Rathinam et al., 2011).  Loss of ITCH function increased NOTCH1 
signaling and resulted in increased proliferation and expansion of the HSC 
population within the bone marrow of Itcha18H/a18H animals as compared to Itch+/+ 
animals.  Transplantation of ITCH deficient HSCs into lethally irradiated ITCH 
sufficient or ITCH deficient animals demonstrated that the enhanced proliferative 
capacity of HSCs was intrinsically regulated.  A number of studies report that 
increased proliferation in HSCs will compromise the regenerative capacity of 
stem cells (K.A. et al., 2015; Yu et al., 2006).  Interestingly, ITCH deficient HSCs 
did not show signs of stem cell exhaustion even with enhanced proliferation and 
increased cell cycle entry. 
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WNT signaling contributes to tissue regeneration by influencing stem cell 
dynamics, proliferation, and specification.  The influence ITCH has in modulating 
canonical WNT signaling is highlighted by the recent identification of two, novel 
WNT signaling components, DVL2 (Wei et al., 2012) and LRP6 (Vijayakumar et 
al., 2017), which are ubiquitylated by ITCH.  DVL promotes canonical WNT 
signaling by interacting with the LRP5/6 co-receptor and Axin to stabilize the 
cytosolic β-catenin pool, which is capable of translocating to the nucleus to 
upregulate WNT-responsive genes.  In 293T cells, the DVL family of proteins 
(DVL1, DVL2, DVL3) were all found to co-precipitate with ITCH.  However, the 
most robust interaction was with DVL2 (Wei et al., 2012).  Exogenous 
overexpression of DVL2, a catalytically active or catalytically dead ITCH E3 
ligase, and ubiquitin confirmed that ITCH ubiquitylates DVL2 and leads to its 
destruction via the proteasome (Wei et al., 2012).  This was further substantiated 
by the absence of DVL2 ubiquitylation when ITCH was knocked-down via siRNA 
treatment.  Functionally, ITCH-mediated ubiquitylation of DVL2 negatively 
regulated WNT signaling.  On the other hand, the targeting of the extracellular 
domain of LRP6 by ITCH also promotes WNT signaling in 293T cells 
(Vijayakumar et al., 2017).  Interestingly, ITCH was found to bind and ubiquitylate 
LRP6 by mass spectrometry.  Instead of promoting LRP6’s degradation, 
ubiquitylation of LRP6 by ITCH promoted endocytosis of the receptor and 
increased Wnt3a-mediated canonical WNT signaling.  The discrepancy in ITCH’s 
function within the WNT signaling pathway is not without precedent.  Within the 
WNT signaling pathway, GSK3β as well as AXIN can positively or negatively 
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regulate WNT signaling in a context-dependent manner (Vijayakumar et al., 
2017).  Thus, ITCH could be an additional player within the regulatory network of 
the WNT signaling pathway that has a dual function. 
 In addition to WNT signaling, the NOTCH signaling pathway also mediates 
stem cell decisions and lineage commitment in the intestine and hematopoietic 
system (Fre et al., 2009; VanDussen et al., 2012; Vooijs et al., 2011).  ITCH 
negatively regulates the HSC population by intrinsically down regulating 
NOTCH1 signaling in HSCs (Rathinam et al., 2011).  Dampening of NOTCH1 
signaling by ITCH likely maintains the HSCs in a quiescent state to conserve this 
population until mature cell lineages need replenishing.  Consistent with this 
assertion, ITCH interacts with the intracellular domain of the NOTCH1 receptor to 
catalytically attach ubiquitin to NOTCH and target it for degradation (Chastagner 
et al., 2008).  The interaction between NOTCH and ITCH appears to be highly 
conserved. In Drosophila melanogaster, genetic loss of the ITCH ortholog 
Suppressor of Deltex rescues Notch signaling (Cornell et al., 1999).  Further 
evidence that NOTCH and ITCH genetically interact is supported by an 
accelerated itchy phenotype that develops in Itcha18H/a18H mice with an activating 
mutation of a Notch1 transgene in T-cells (Matesic et al., 2006).  
 On another note, moribund Itcha18H/a18H animals exhibit signs of barrier 
dysfunction (Kathania et al., 2016). When fluorescently conjugated dextran, a 
macromolecule that is able to passively diffuse through the intestinal epithelium, 
was administered by oral gavage to Itch+/+ or Itcha18H/a18H animals, increased 
levels of FITC-dextran were present within the serum of Itcha18H/a18H animals as 
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compared to Itch+/+ control animals (Kathania et al., 2016).  In contrast, young 
adult ITCH deficient animals do not appear to have a compromised intestinal 
barrier, suggesting that barrier dysfunction is likely exacerbated by an 
inappropriate inflammatory response within these animals (Marino et al., 2014).  
On another note, a potential role for ITCH in altering tight junction is highlighted 
by the ITCH-mediated degradation of OCCLUDIN (Traweger et al., 2002).  
Endogenous ITCH and OCCLUDIN co-immuoprecipitated in embryonic tissue 
from a mouse at day 13 of gestation.  Further, ITCH was confirmed to 
polyubiquitylate OCCLUDIN in 293T cells and alter its stability.  
 Accumulating evidence highlights a specific role for ITCH in apoptosis.  
Among ITCH’s numerous targets are p63 (Rossi et al., 2006) and p73 (Rossi et 
al., 2005), essential transcription factors involved in cell cycle regulation and 
apoptosis.  Both full-length (TA) p63 and p73 are transcriptionally active and can 
induce cell cycle arrest that results in apoptosis (Murray-Zmijewski et al., 2006).  
Alternatively, dominant-negative (ΔN) isoforms can also be generated from an 
alternative promoter within the p63 or p73 genes.  The ratio between the TA and 
the ΔN isoforms influences the biological outcome.  The E3 ligase ITCH has 
been demonstrated to target both isoforms of p63 and p73.  In HEK293 cells, 
ITCH was shown to bind and ubiquitylate both TAp63 and ΔNp63 that 
consequently lead to their destruction (Rossi et al., 2006).  Additionally, the 
primary culture of keratinocytes derived from Itcha18H/a18H animals retained the 
expression of ΔNp63 longer during keratinocyte differentiation as compared to 
Itch+/+ keratinocytes.  As with p63, ITCH also binds, ubquitylates, and degrades 
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TAp73 and ΔNp73 (Rossi et al., 2005).  In response to DNA damage, ITCH 
expression is reduced, which likely leads to the accumulation of TAp73 to induce 
cycle arrest and apoptosis.  
 ITCH also targets and promotes the degradation of other molecules 
involved in apoptosis, including TXNIP (Zhang et al., 2010), LATS1 (Ho et al., 
2011), and c-FLIP (Chang et al., 2006).  TXNIP is a modulator of cell redox 
homeostasis and is induced in response to cell stress, which allows reactive-
oxygen species to accumulate and initiate cell death.  In vitro and in vivo 
ubiquitylation assays confirmed that ITCH can bind, ubiquitylate, and degrade 
TXNIP (Zhang et al., 2010).  Consequently, loss of ITCH promoted accumulation 
of reactive-oxygen species and apoptosis in response to the chemotherapeutic 
agent etoposide.  Additionally, the targeting of the tumor suppressor LATS1 by 
ITCH promotes cell survival by increasing proliferation and decreasing apoptosis 
(Ho et al., 2011).  Knockdown of endogenous ITCH via shRNA treatment in 
MDA-MB231 cells (derived from a human breast adenocarcinoma) decreased 
proliferation and increased apoptosis.  More importantly, this phenotype can be 
reversed by shRNA knockdown of endogenous LATS1 effectively demonstrating 
that ITCH is a negative regulator of LATS1.  
 The presence of ITCH within Tregs controls the inflammatory response of 
Th2 cells.  Loss of ITCH expression under the control of a Treg specific (Foxp3) 
promoter (Itchfl/fl; Foxp3Cre/Cre) resulted in massive lymphocytic infiltrate in the 
lung, skin, stomach, and liver, skin lesions, and chronic T-cell activation (H. S. Jin 
et al., 2013).  Furthermore, severe inflammation was localized to the lungs of 
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Itchfl/fl; Foxp3Cre/Cre animals as compared to ITCH sufficient control animals when 
subjected to an antigen-induced airway inflammation model of asthma (H. Jin et 
al., 2013).  Interestingly, Itchfl/fl; Foxp3Cre/Cre Tregs adopted a Th2 phenotype, 
secreting IL4-, IL-5, IL-10, and IL-13, while still retaining their suppressive 
capacity in an adoptive T-cell transfer model of colitis.  Furthermore, IL-4, IL-5, 
and IL-10 cytokine levels were also increased in CD4+ T-cells derived from Itchfl/fl; 
Foxp3Cre/Cre animals as compared to control animals, suggesting that a Th2-
mediated inflammatory response was initiated in Itchfl/fl; Foxp3Cre/Cre animals.    
 In addition to regulating T-cell differentation, ITCH has been found to 
influence macrophage signaling.  ITCH regulates p38, JNK, and NFκB signaling 
within macrophages via its interaction with NOD2 and RIP2 (M. F. Tao et al., 
2009).  NOD2 is an intracellular pattern recognition receptor that binds to 
fragments of a peptidoglycan that have invaded epithelial cells of the small 
intestine.  Subsequently, a cytokine response is initiated by NOD2 that precisely 
controls the type, amount, and duration of cytokines that are necessary to 
effectively clear the bacterial pathogen while, at the same time, limiting this 
reaction to prevent an aberrant inflammatory response that could lead to tissue 
destruction (Caruso et al., 2014).  Generation of the cytokine response hinges on 
the interaction of NOD2 with ubiquitylated RIP2 to activate p38, JNK, and NFκB 
signaling.  In response to a Listeria monocytogenes infection in HT-29 cells, K63-
linked polyubiquitylaton of RIP2 was mediated by the E3 ligase ITCH, which 
facilitated binding with NOD2 (M. F. Tao et al., 2009).  Interestingly, ITCH-
mediated ubiquitylation of RIP2 selectively promoted p38-induced JNK activation 
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while compromising NFκB signaling.  Further, this interaction was also confirmed 
in bone marrow-derived macrophages from Itcha18H/a18H animals that were 
stimulated with mumuryl dipeptide (MDP), a peptidoglycan fragment that binds to 
NOD2 to initiate cytokine responses.  MDP stimulation resulting in increased 
expression of NFκB gene targets in the Itcha118H/18H animals as compared to 
Itch+/+ bone marrow-derived macrophages.  In addition to ITCH’s ability to 
downregulate NFκB signaling in response to MDP, ITCH also attenuates NFκB 
signaling induced by TNFα (Shembade et al., 2008).  Mechanistically, the binding 
of ITCH to PPXY consensus sequences of A20, an ubiquitin-editing enzyme, 
modifies RIP2 ubiquitylation to inhibit NFκB activation.  Further evidence 
supporting the importance of ITCH-mediated TNF-α -induced NFκB signaling is 
highlighted by phosphorylation of ITCH by the IKK kinase family, an essential 
component that is required for NFκB activation, which inhibits its regulation over 
NFκB to prolong NFκB duration (Perez et al., 2015). 
 Expanding on this current body of literature, our studies aim to elucidate 
the role of the E3 ligase ITCH in the small intestine.  Here we provide evidence 
that loss of ITCH function in the small intestine influences epithelial homeostasis 
in a cell autonomous and non-cell autonomous manner.   
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Figure 1.1.  Cell types that comprise the small intestinal mucosa.  The 
mucosa of the small intestine is composed of the epithelial barrier that 
separates the external environment from the body’s internal milieu and the 
immune compartment.  The epithelium is composed of CBC stem cell and +4 
stem cells that reside at the base of the crypt interspersed between Paneth 
cells.  Enterocytes, goblet cells, and enteroendocrine (EE) cells line the villi of 
the small intestine.  The immune compartment, which underlies the epithelium, 
is composed of immune cells that mediate innate and acquired immune 
responses.    
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Maintenance of the intestinal mucosa is driven by local signals that 
coordinate epithelial proliferation, differentiation, and turnover in order to 
separate antigenic luminal contents from the host’s immune system.  Breaches in 
this barrier promote gastrointestinal pathologies ranging from inflammatory bowel 
disease to cancer.  The ubiquitin ligase ITCH is known to regulate immune 
responses, and loss of function of ITCH has been associated with 
gastrointestinal inflammatory disorders, particularly in the colon.  However, the 
small intestine appears to be spared from this pathology.  Here we explored the 
physiological mechanism that underlies the preservation of mucosal homeostasis 
in the small intestine in mice lacking ITCH (Itcha18H/a18H).   Histological analysis of 
the small intestines from young adult mice revealed architectural changes in 
animals deficient for ITCH, including villus blunting with cell crowding, crypt 
expansion, and thickening of the muscularis propria relative to age-matched mice 
sufficient for ITCH.  These differences were more prominent in the distal part of 
the small intestine and were not dependent upon lymphoid cells.  Underlying the 
observed changes in the epithelium were expansion of the Ki67+ proliferating 
transit amplifying progenitor population and increased numbers of terminally 
differentiated mucus-secreting goblet and anti-microbial producing Paneth cells, 
which are both important in controlling local inflammation in the small intestine 
and are known to be dysregulated in inflammatory bowel disease.  Homeostasis 
in the small intestine of Itcha18H/a18H animals was maintained by increased cell 
turnover, including accelerated migration of epithelial cells along the crypt-villus 
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axis and increased apoptosis of epithelial cells at the crypt-villus junction.  
Consistent with this enhanced turnover, Itcha18H/a18H mice carrying the Min 
mutation (Itcha18H/a18H; ApcMin/+) displayed a 76% reduction in tumor burden as 
compared to ApcMin/+ littermates with normal levels of ITCH.  These findings 
highlight the role of ITCH as an important modulator of intestinal epithelial 
homeostasis. 	
2.2 Introduction 
 In the small intestine, the mucosal epithelium is a folded monolayer of 
columnar cells that is organized into crypts, which invaginate into the underlying 
mesenchyme, and villi, which project into the lumen.  This structure is ideally 
suited to provide an essential, physical barrier between the host and its 
environment that must facilitate the absorption of nutrients while simultaneously 
preventing the loss of fluids and electrolytes as well as the entry of 
microorganisms into the body (van der Flier and Clevers, 2009).  When the 
intestinal epithelium is disrupted, commensal and pathogenic microbes gain 
access to the host organism, prompting an inflammatory response, which can 
itself cause further tissue damage if not appropriately regulated (Turner, 2009).  
Thus, communication between mucosal immune cells (particularly those of the 
myeloid lineage) and the overlying epithelium is essential in maintaining gut 
homeostasis and in controlling intestinal inflammation (Van Der Gracht et al., 
2016).  Preservation of barrier function is dependent, in part, upon the continuous 
renewal of intestinal epithelial cells (Bischoff et al., 2014).  Regeneration of the 
small intestinal epithelial architecture is a highly complex process that relies on 
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the balanced coordination of cellular proliferation within the crypts of Lieberkühn, 
preservation of epithelial function through cellular differentiation, and homeostatic 
cell migration along the crypt-villus axis (Pellettieri and Alvarado, 2007).  
Dysregulation of any one of these aspects of epithelial maintenance can drive a 
diverse collection of pathologies, ranging from improper nutrient absorption to 
inflammatory bowel disease (IBD) to intestinal carcinogenesis (J. M. Williams et 
al., 2015). 
 The rapid and constant renewal of the intestinal epithelium is initiated by 
the multipotent crypt base columnar (CBC) stem cells that reside at the bottom of 
the crypts (Barker et al., 2007a).  Upon cellular division, the CBC stem cells give 
rise to a rapidly dividing transit-amplifying (TA) population that will commit and 
differentiate into the five major post-mitotic cells of the small intestinal epithelium 
(Barker, 2013).  The most abundant of these is the absorptive enterocyte. The 
remaining four post-mitotic cell types originate from the secretory cell lineage and 
include the mucus secreting goblet cells, anti-microbial secreting Paneth cells, 
hormone producing enteroendocrine cells, and tuft cells (Barker, 2013).  With the 
exception of Paneth cells, which migrate deeper into the crypt, the other four 
post-mitotic cell types normally move onto the villus where they continue to travel 
upward along this axis, eventually being sloughed off at the tip into the lumen.  
Because of the rapid turnover of the small intestinal epithelium, both spatial and 
temporal timing of signals are paramount.  Accumulating evidence suggests that 
post-translational modifications such as ubiquitylation are essential in the 
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regulation of these signals to promote tissue homeostasis (Strikoudis et al., 
2014). 
 Protein ubiquitylation is a highly conserved process characterized by the 
attachment of an ubiquitin molecule to a lysine residue within a target protein via 
the sequential action of three enzymatic/scaffolding proteins: the ubiquitin-
activating enzyme (E1), the ubiquitin-conjugating enzyme (E2), and the ubiquitin 
ligase (E3). Ubiquitylation of a target substrate can lead to its degradation in the 
proteasome or lysosome, to its altered function, or to a change in its subcellular 
localization (Popovic et al., 2014).  The E3 ubiquitin ligase ITCH was originally 
identified when the molecular etiology of the radiation- and 5-hydroxyurea-
induced a18H mutation was elucidated, revealing a paracentric inversion on the 
distal end of mouse chromosome two, the breakpoints of which disrupted both 
the Itch and Agouti loci (William L. Perry et al., 1998).  Animals homozygous for 
this null mutation of Itch (Itcha18H/a18H) display lymphoproliferation in the spleen, 
lymph nodes, and thymus, atopic dermatitis, and pulmonary interstitial 
inflammation with alveolar proteinosis which culminates in death around 6-8 
months of age on a C57BL/6J background (C. M. Hustad et al., 1995) whereas 
animals heterozygous for this mutation appear relatively unaffected with a normal 
lifespan (C. M. Hustad et al., 1995; Parravicini et al., 2008).  The skin and lung 
inflammation in these animals occurs in the absence of known pathogen 
exposure, implying that immune activation may result from inappropriate 
inflammatory responses to environmental antigens at mucosal surfaces.  
Consistent with this assertion, loss of ITCH function has also been associated 
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with a gastrointestinal inflammatory phenotype in both mice and humans 
(Kathania et al., 2016; Lohr et al., 2010; Ramon et al., 2011; M. Tao et al., 2009).  
In mice, this appears to be more severe in the colon with moribund Itcha18H/a18H 
mice developing spontaneous colitis characterized by an increase in mixed 
inflammatory infiltrate and colonic epithelial destruction that was not observed in 
their age- and gender- matched wild type counterparts and has been 
hypothesized to be lymphoid-driven (Kathania et al., 2016).  However, only mild 
inflammation has been observed in the small intestine of similarly aged (i.e., 5-7 
month old) animals lacking ITCH (Kathania et al., 2016; Ramon et al., 2011).	 
This led us to hypothesize that, owing to differences in architecture, function, and 
microbiota composition, additional compensatory pathways may be activated in 
animals lacking ITCH in order to better maintain homeostasis in the small 
intestine as compared to what has already been described for the colon.  Using 
the previously characterized Itcha18H/a18H mouse model, we found that, in the 
distal small intestines of Itcha18H/a18H animals, there were increased numbers of 
goblet and Paneth cells which correlated with increased proliferation of 
progenitor cells and expansion of the crypts.  However, overall, homeostasis and 
cell number was maintained in these animals by accelerated migration and 
increased apoptosis of epithelial cells as compared to wild type animals.  
Furthermore, these changes in epithelial cell dynamics were associated with a 
76% reduction in small intestinal tumor burden in animals lacking Itch expression 
on an ApcMin/+ background as compared to ITCH-sufficient ApcMin/+ littermates.		
Collectively, these data demonstrate a previously unappreciated role for ITCH in 
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the regulation of intestinal epithelial homeostasis, and provide further insight into 
regional differences in this process along the intestines. 
2.3 Materials and Methods 
Animals	
 Animals homozygous for a null allele of Itch (Itcha18H/a18H) have been 
previously described (C. M. Hustad et al., 1995).  For this line, the a18H allele was 
backcrossed to C57BL/6J for 27 generations.  Therefore, age-matched male and 
female C57BL/6J mice were used as referent controls (Itch+/+) in the indicated 
experiments. To study the effect of this mutation on APC-induced tumorigenesis, 
a two generation intercross was performed.  Specifically, Itcha18H/a18H mice were 
bred to ApcMin/+ animals (JAX stock #002020) to produce Itcha18H/+; ApcMin/+ and 
Itcha18H/+; Apc+/+ offspring, which were interbred to generate Itch+/+; Apc+/+, 
Itcha18H/a18H; Apc+/+, Itcha18H/a18H; ApcMin/+, and Itch+/+; ApcMin/+ animals for analysis.  
To assess the contribution of lymphocytes to the loss of function ITCH 
phenotype, Itcha18H/a18H animals were bred to B6.129S7-Rag1tm1Mom/J (Rag1-/-) 
mice (Jackson Laboratories stock number #002216) as previously described 
(Shembade et al., 2008).  Since the Rag1-/- mice are severely 
immunocompromised, all animals from this cross were reared and maintained 
under high barrier conditions, following the recommendations of Jackson 
Laboratories.  For all experiments, both genders were represented in each 
genotype in all experiments.  All experiments were conducted in full compliance 




 Small intestines derived from young adult animals were flushed with 
phosphate-buffered saline (PBS) after being cut into three equally sized 
segments (designated proximal, middle and distal), opened longitudinally, and 
fixed overnight with either 4% paraformaldehyde or with 10% neutral buffered 
formalin.  Swiss-rolled intestinal tissues or were paraffin-embedded and 
sectioned at 5µm.  Hematoxylin and eosin (H&E) staining was performed to 
assess tissue morphology.  Alcian blue and nuclear fast red staining was 
performed by applying alcian blue, pH 2.5 for 30 minutes at 25°C followed by 
0.1% nuclear fast red for 5 minutes.  The Grimelius stain was performed 
according to previously published methodology (Grimelius, 2004).  Briefly, tissue 
sections were treated with a 0.03% silver nitrate staining solution (Fisher 
Scientific, S181) for 3 hours at 60°C followed by a 2 minute treatment with a 
silver reducing solution (5% Sodium Sulfite/1% Hydroquione) that was pre-
warmed to 58°C. Alkaline phosphatase (AP) staining was carried as previously 
described (Burstone, 1958).  Specifically, a 2% naphthol AS-MX phosphate 
solution diluted in N,N-dimethyformamide was added to a 50%/50% mixture of 
Tris buffer, pH 8.74 and distilled water to create a final solution containing 0.5% 
napththol AS-MX phosphate in Tris buffer.  This was then filtered through a 
0.45µm filter.  Slides were placed in the solution for 45 minutes at 37°C and 
washed before counterstaining with hematoxylin. 	
Immunohistochemistry and Immunofluorescence 	
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 For immunohistochemistry (IHC), antigen unmasking was performed using 
target retrieval solution for Ki67 (Dako # S1699) or 10 mM Tris-HCl/ 1 mM 
ethylenediaminetetraacetic acid (EDTA), pH=9 for 30 minutes at 95°C for 
cleaved-caspase 3.  Sections were blocked in a solution containing 10% normal 
goat serum, 2% bovine serum albumin, and 0.2% Triton X-100 in Tris buffered 
saline (10mM Tris-HCL, pH 7.6, 150mM NaCl).  An additional hydrogen 
peroxidase block was performed for 20 minutes at 25°C.  The primary antibodies 
recognizing either Ki67 (B56, BD Pharmingen, 1:100) or cleaved-caspase 3 (Cell 
Signaling Technologies, #9664, 1:100) were diluted in Tris buffered saline 
containing 1% normal goat serum and 0.1% Triton X-100 and incubated on 
sections in a humidified chamber overnight at 4°C.  The antibody was visualized 
using the EnVision+ system-HRP per the manufacturer’s instructions (Dako # 
K4006).  Brightfield images were acquired on a Zeiss Axio Imager A1 equipped 
with an AxioCam MRc5 camera. 	
Tissue immunofluorescence for lysozyme was performed as previously 
described (Basheer et al., 2015)		with the following modifications: 5 µm paraffin 
sections were blocked for 1 hour before applying an anti-lysozyme antibody 
(RP028, Diagnostic BioSystems, 1:100) overnight at 4ºC.  AlexaFluor659-
conjugated goat anti-rabbit secondary (Jackson ImmunoResearch) was applied 
at a 1:500 dilution for 1 hour before mounting sections in Fluoro-gel II with DAPI 
(17985-51, Electron Microscopy Sciences).  Phase contrast-coupled fluorescent 
images were acquired on a Leica DMI6000B epifluorescence microscope 
equipped with a Hamamatsu ORCA-R2 CCD camera.  	
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Quantitative Measurements: Histological Measurements, Cell Proliferation, and 
Post-Mitotic Cell Differentiation	
 All parameters quantified by histological examination were assessed in the 
distal segment from four or five 8-10 week old animals of each genotype (i.e., 
Itch+/+, n=4 or 5 and Itcha18H/18H, n=4 or 5).  Crypt and villus areas were quantified 
using a minimum of 25 well-oriented crypt or villus structures from at least seven 
different 10x fields per animal.  The crypt or villus unit was outlined using the 
polygon tool in ImageJ, and the areas were quantified in µm2.  Cell proliferation 
was measured by first manually counting the total number of Ki67+ cells stained 
by IHC in 25 well-oriented crypts from a minimum of nine 20x fields per animal.  
Then, the total number of cells in those same crypts was determined by 
enumerating the nuclei stained with Ki67 and/or hematoxylin.  To calculate the 
average percentage of Ki67+ cells in a crypt, the number of Ki67+ cells was 
normalized to total cell number for that crypt and expressed as a percentage. 	
            Phase contrast-coupled fluorescence images immunostained with an 
anti-lysozyme antibody were used to determine average Paneth cell number.  In 
particular, individual Paneth cells were delineated using the cell membrane 
highlighted by phase-contrast microscopy, the DAPI-stained nucleus, as well as 
reactivity with the anti-lysozyme antibody.  Paneth cells were counted in 30 
crypts from a minimum of twelve 20x fields per animal.  Average goblet cell and 
enterocyte number was determined by staining sections with alcian blue and a 
nuclear fast red counterstain.  Goblet cells were recognized on the basis of the 
reactivity of their cytoplasm with alcian blue and by their characteristic shape, 
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while enterocytes were not reactive with alcian blue and were instead identified 
by their typical columnar appearance.  Both types of cells were counted on 30 
villi in at least eight different 10x fields per animal.  Similarly, enteroendocrine 
cells identified through Grimelius stain were counted from 30 villi in eight different 
10x fields per animal. 	
Bromodeoxyuridine (BrdU) Migration Assay	
 Twelve young adult Itch+/+ and twelve young adult Itcha18H/a18H animals 
were intraperitoneally injected with 100 mg/kg BrdU (B5002, Sigma) dissolved in 
sterile PBS.  Three animals of each genotype were randomly assigned to one of 
three cohorts and euthanized at 2, 24, 48, or 72 hours post-injection.  The small 
intestines from these animals were cut into equally sized proximal, middle, and 
distal segments and flushed with PBS prior to 4% paraformaldehyde fixation, 
paraffin-embedding, and sectioning at 5 µm.  IHC was performed as described 
above using anti-BrdU (3D4, BD Pharmingen, 1:8000).  Images were acquired by 
bright field microscopy on a Zeiss Axio Imager A1 equipped with an AxioCam 
MRc5 camera and subsequently analyzed using ImageJ to determine migration 
and villus lengths.  Percent cell migration was assessed from 25 villi in at least 
five different 10x fields per animal and calculated by normalizing the length of the 
furthest migrated epithelial BrdU+ cell from the base of the villus to the entire 
length of the villus from BrdU immunostained sections and converting to a 
percentage. 
 For figure presentation, brightfield images of sections immunostained with 
an anti-BrdU antibody were transformed to a spectral image using ImageJ.  This 
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was accomplished by first inverting the images and then converting them to 8-bit 
gray scale.  In order to specifically highlight cells that had taken up the BrdU 
label, the pixel intensity for those nuclei staining only for hematoxylin was 
subtracted out by calculating their background values.  Specifically, for each 
converted image, a minimum of six different BrdU- nuclei were identified 
throughout the image and the pixel value for each was determined using a 
constant, ImageJ pre-defined area for the cursor.  These values were averaged 
and considered the background level for each image.  A similar background level 
was calculated in all the images except the 72 hour Itcha18H/18H image, which was 
higher.  To account for this discrepancy, 55 pixels were subtracted from all the 
images except the 72 hour image captured from the Itcha18H/a18H animal in which 
67 pixels were subtracted due to high background.  Finally, the royal look-up 
table was applied to all images to re-colorize them. 	
Transmission Electron Microscopy	
 The small intestine from four young adult animals of each genotype was 
cut into three equally sized segments, flushed with PBS, and then opened 
longitudinally.  The proximal segment was dissected into 4mm2 pieces which 
were fixed in 2% glutaraldehyde/2% paraformaldehyde and secondarily post-
fixed in buffered 1% osmium tetroxide/1.5% potassium ferricyanide.  After 
dehydrating in ethanol, the samples were infiltrated and embedded in PolyBed 
812 epoxy and allowed to polymerize for at least 48 hours at 60°C.  At that time, 
blocks were sectioned at approximately 90 nm on a Leica UltraCut R and post 
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stained with 2% uranyl acetate (aq) and Hanaichi’s calcined lead citrate.  Images 
were obtained on a JEM 1400+ with an AMT mid-mount camera.   
Polyp counts	
 The small intestines from 15 week-old male and female Itch+/+; Apc+/+, 
Itcha18H/a18H; Apc+/+, Itcha18H/a18H; ApcMin/+ , and Itch+/+; ApcMin/+ animals were cut 
into 4 equally sized segments, flushed with PBS, opened longitudinally, and fixed 
overnight in 10% neutral buffered formalin.  The samples were stained with 0.1% 
methylene blue to identify tumors.  Total tumor number for each animal was 
assessed by counting and tabulating the polyp number along the entire axis of 
the small intestine by an observer blinded to genotypes.  
Isolation of Mouse Intestinal Villi  
Isolation of the villus fraction was performed as previously described 
(Huang et al., 2017) with the following modifications.  To isolate adequate protein 
levels from just the villus fraction, the proximal most 10 cm of small intestine from 
two age-, gender- and genotype-matched animals was pooled.  The small 
intestines from 8-10 week old Itch+/+ and Itcha18H/a18H  animals were washed in 
PBS (containing Mg2+ and Ca2+) before opening longitudinally to expose crypts 
and villi.  The proximal segment was cut into 3 to 5 mm pieces and incubated in 
ice-cold Dulbecco’s PBS (DPBS, Cellgro # 21-031-CV).  The DPBS was 
decanted from the previous step prior to incubating the intestinal pieces in ice-
cold DPBS supplemented with 1 mM EDTA for 10 minutes at 4°C on a rocking 
platform.  The 1mM EDTA was discarded, and the intestinal pieces were 
resuspended in fresh DPBS before being shaken vigorously 10-15 times to 
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dislodge the attached cells.  The cells contained in the DPBS were labeled 
Fraction 1.  To isolate cells from the villi, the fraction was filtered through a 70-µm 
nylon filter (VWR, #10199-656).  The cells that remained on the filter were 
deemed the villus fraction.  This process was subsequently followed for a total of 
6 fractions, replacing each solution with fresh 1mM EDTA or DPBS prior to 
filtration.  Fractions 3-6 contained pure villi and were pooled together before 
protein extraction.  To isolate villi from the small intestines from Itcha18H/a18H 
animals, the EDTA incubation time was amended to 5 minutes for Fractions 1-6. 
All steps were performed at 4°C.  
Protein Extraction and Western Blotting  
Isolated villi were lysed in ice-cold RIPA buffer (150mM NaCl, 1% Triton X 
-100, 0.5% sodium deoxycholate,0.1% SDS, 50mM Tris pH 8.0) supplemented 
with 5mM EDTA,10mM NaF, 2mM NaVO4, and  protease inhibitors (P8340, 
Sigma, 1:100).  For Western blotting, 40 µg of protein per sample were separated 
using a 4%-15% Mini-PROTEAN TGX gel (Biorad, #456-1084) then transferred 
to a PVDF membrane (Biorad, # 162-0177).  The membrane was blocked in 5% 
milk in TBST (10mM Tris-HCL, pH8, 150mM NaCl, 0.05% Tween-20) for 1 hour 
at 25ºC.  The following primary antibodies were incubated overnight at 4°: 
GAPDH (Santa Cruz, 6C5, 1:2000), Itch (BD Transduction, 611198, 1:1000), N-
cadherin (Cell Signaling Technology, D4R1H, 1:1000), and Vimentin (Cell 
Signaling Technology, D21H3, 1:1000).  Following primary antibody incubation, 
the appropriate HRP-conjugated rabbit (Biorad, #STAR208P,1:30,000) or mouse 
IgG secondary (Biorad, #STAR207P,1:20,000. was incubated for 1 hour at 25°C.  
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Signals were visualized using ECL reagent (Millipore, Immobilon Western, 
WBKLS0500) and the FluorChem E Chemiluminescent Western Blot Imaging 
System (ProteinSimple).  Normalization and quantification of band intensities was 
performed with AlphaView software (ProteinSimple). 
Statistics	
 Statistical comparisons of Ki67+ cells, Paneth cells, goblet cells, 
enteroendocrine cells, enterocytes, BrdU migration, and tumor counts (reported 
as mean and standard deviation (SD) or standard error of the mean (SEM), as 
indicated, 2-tailed unpaired t-test for mean comparisons, Mann-Whitney test for 
comparing non-parametric medians of non-normally distributed enteroendocrine 
cells, and one-way ANOVA with a post hoc Tukey correction for tumor counts) 
were performed in Microsoft Excel or Prism Software (GraphPad Software, Inc) 
and plotted using Prism software.  A p-value < 0.05 was considered statistically 
significant.  	
2.4 Results 
Itcha18H/a18H animals have altered small intestinal morphology   
 Using a previously described loss of function mouse model (C M Hustad 
et al., 1995), the role of ITCH in intestinal homeostasis was examined by first 
characterizing the impact that loss of ITCH has on the morphology of the small 
intestines in young adult animals.  This was accomplished by harvesting the 
small intestines from four or five 8-10 week old mice of each genotype and 
separately examining the architecture of the proximal, middle, and distal thirds of 
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the intestine to account for known regional variations in structure.  Interestingly, 
examination of H&E stained sections from the various segments revealed 
hyperplasia of the crypts which became more prominent caudally along the small 
intestinal tract of Itcha18H/a18H animals as compared to ITCH sufficient referent 
controls (Fig. 2.2.A).  Additionally, villus blunting (with more disorganized 
epithelial cell organization) as well as thickening of the muscularis propria were 
observed in the distal portion of animals lacking ITCH (asterisk, Fig. 2.2.A) and 
was associated with occasional mild mucosal inflammation (arrow, Fig. 2.2.A).  
These phenotypes were also noted in Itcha18H/a18H; Rag1-/- animals which lack 
functional lymphoid cells (Fig. 2.3 and (M. Tao et al., 2009)) indicating that these 
changes were dependent on cues garnered from epithelial and/or innate immune 
cells.  To quantify the changes in size of the crypts and villi in Itcha18H/a18H 
animals, we measured the area of 25 crypts and 25 villi from Itch+/+ and 
Itcha18H/a18H animals in each region of the small intestine.  Consistent with the 
apparent crypt expansion noted microscopically, the crypt area was significantly 
increased in the middle and distal segments of Itcha18H/a18H intestine as compared 
to age-matched wild type animals (19,772.23 µm2 vs 11,165.53.12 µm2 and 
22,653.25 µm2 vs. 15,780.51 µm2, respectively) as determined by 2-tailed, 
unpaired t-test (Fig. 2.2.B).  While there was a trend toward increased villus area 
across the entire small intestine, only in the distal segment was a statistically 
significant increase noted in animals lacking ITCH relative to those that were 
sufficient for ITCH (62,056.18 µm2 vs. 47,144.47 µm2, Fig. 2.2.C). Therefore, for 
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our subsequent analyses, we focused on changes in the distal segment of the 
small intestine. 
Expansion of the crypt in adult Itcha18H/a18H animals is associated with an increase 
in the number of proliferating cells and Paneth cells in the distal small intestine 
 As there was a statistically significant increase in the crypt area of 
Itcha18H/a18H animals relative to Itch+/+ controls, we hypothesized that an increase 
in cell number might underlie this expansion.  Indeed, when the total number of 
cells in the crypts was calculated in tissues derived from five young adult animals 
of each genotype, a statistically significant increase in cell number was found in 
animals lacking ITCH (Fig. 2.4).  To determine which cell populations might be 
expanded in the crypt, we first performed IHC using an antibody that recognizes 
the proliferation marker Ki67 since crypts are mostly composed of rapidly 
proliferating progenitor TA cells (Fig. 2.5.A).  Upon evaluation of 25 well-oriented 
crypts from a minimum of nine 20x fields per animal (n=5 for each genotype), 
40.14±4.91 (SD) Ki67+ cells on average were found in the crypts of the 
Itcha18H/a18H animals whereas 29.056±2.91 (SD) Ki67+ cells on average were 
found in the crypts of Itch+/+ controls, and this difference was found to be 
statistically significant by 2-tailed, unpaired student t-test (Fig. 2.5.B).  Although 
there was an increase in the absolute number of Ki67+ cells detected in 
Itcha18H/a18H animals, there was no difference in the percentage of proliferating 
cells within the crypt when compared to Itch+/+ controls (Fig. 2.5.B), suggesting 
that progenitors cells were not the only cell type contributing to this increase in 
total cell number within the crypt.  
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 In addition to stem and progenitor cells, Paneth cells also reside in the 
crypt.  To test whether increased numbers of Paneth cells might be contributing 
to the increased crypt area observed in Itcha18H/a18H mice, small intestinal 
sections from five animals of each genotype were immunostained with an 
antibody recognizing lysozyme, a mature Paneth cell maker (Fig. 2.5.C), allowing 
for the enumeration of Paneth cells in 30 crypts from a minimum of twelve 20x 
fields per animal.  Interestingly, there was a significant increase in Paneth cells in 
the crypts of Itcha18H/a18H animals (6.82±0.64, SEM) compared to Itch+/+ controls 
(5.17±0.19, SEM).  When the means were compared by unpaired, 2-tailed 
student t-test, the difference was found to be statistically significant (Fig. 2.5.D).  
Taken together, these results indicate that increases in the number of 
proliferating progenitor cells and differentiated Paneth cells contributed to the 
crypt expansion observed in Itcha18H/a18H animals.  
Itcha18H/a18H animals have increased numbers of goblet cells along the villi of the 
distal small intestine  
 The epithelium of the small intestine is comprised of a variety of different 
cell types that arise from the rapidly dividing TA progenitor population found 
within the crypt.  Since there was an expansion of proliferating cells in the crypts 
of mice lacking ITCH and since Paneth cells are only one of several different 
kinds of differentiated cells contributing to the epithelial architecture of the small 
intestine, it was a distinct possibility that other classes of post-mitotic cells which 
localize to the villi could also be altered in Itcha18H/a18H animals.  To determine if 
goblet and enteroendocrine cells were also affected in Itcha18H/a18H animals, we 
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stained small intestinal tissue sections obtained from four animals of each 
genotype to specifically highlight each type of post-mitotic secretory cell.  In 
particular, goblet cells were visualized using alcian blue, a stain identifying 
glycosylated mucins (Fig. 2.6.A), and the cell number determined by counting 
positively stained cells on 25 villi in at least eight different 10x fields per animal.  
Interestingly, there was a 48% increase in the number of goblet cells on the villus 
of Itcha18H/18H animals as compared to Itch+/+ animals (10.93±0.98 (SEM) vs. 
7.37±0.69 (SEM)), and this difference was statistically significant by 2-tailed, 
unpaired t-test (Fig. 2.6.D).  However, no statistically significant difference in the 
number of enteroendocrine cells (visualized by Grimelius stain, which reacts with 
the hormones in the secretory granules, and quantified in 30 villi from eight 
different 10x fields per animal) was observed in the distal small intestine derived 
from Itcha18H/18H mice as compared to those derived from age-matched ITCH 
sufficient controls.  Because of the left-shifted distribution of enteroendocrine 
cells in animals of both genotypes, a Mann-Whitney comparison of non-
parametric medians was performed to determine significance for this population 
(Fig. 2.6.B and 2.6.D).  
 In addition to the post-mitotic cells derived from the secretory lineage, the 
absorptive enterocyte (the most abundant cell type in the small intestine) is 
essential to the structure and function of the small intestine.  For this reason, 
mature enterocytes were characterized by staining distal intestinal tissues 
derived from young adult mice of both genotypes with AP in order to visualize the 
brush boarder (which is critical in nutrient absorption).  When examining the 
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sections of Itch+/+ and Itcha18H/a18H derived tissues, no appreciable difference in 
AP staining was seen, suggesting that the overall architecture and functionality of 
the enterocytes was preserved even in the absence of ITCH (Fig. 2.6.C).  To 
determine whether there was instead a difference in enterocyte number between 
the two genotypes, the number of enterocytes was determined using alcian 
blue/nuclear fast red stained distal intestinal sections from four animals of each 
genotype.  For this analysis, enterocytes were identified on the basis of their 
nuclear morphology and typical columnar cell profile and were counted from 25 
villi in at least eight different 10x fields per animal.  Although there was a trend 
towards reduced enterocyte number in the ileum of Itcha18H/a18H animals 
(48.52±2.38, SEM) as compared to the control (54.67±3.13, SEM, Fig. 2.6.D), 
this difference was not statistically significant by two-tailed unpaired t-test 
(p=0.07).  Additionally, there was no statistically significant difference between 
genotypes in the total number of epithelial cells on those same villi (Fig. 2.7).  
Collectively, these data suggest that proliferating progenitor cells in the 
Itcha18H/a18H animals still retain the ability to give rise to both the absorptive and 
secretory cell lineage, albeit the percentage of the cell types are altered. 
Itcha18H/a18H animals have increased epithelial cell turnover 
 Because Itcha18H/a18H animals have an increase in the number of 
proliferating progenitor cells within the crypt compartment yet still have 
comparable numbers of post-mitotic cells on the villus as age-matched ITCH 
sufficient controls, we speculated that animals lacking ITCH might have 
increased apoptosis of epithelial cells.  To evaluate steady-state apoptosis levels, 
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IHC was performed on sections derived from the distal small intestines of four 
young adult animals of each genotype using an antibody that recognizes 
cleaved-caspase 3, a critical executioner for apoptosis.  As would be expected 
under normal conditions, very few apoptotic cells could be detected in Itch+/+ 
intestines, except for the rare epithelial cell at the tip of a villus that was 
presumably in the process of being sloughed off  (Fig. 2.8).  In addition to the 
occasional cleaved-caspase 3+ cell at the tip of a villus, there were a number of 
apoptotic cells at the crypt-villus junction in Itcha18H/a18H animals that were never 
seen in the intestines derived from Itch+/+ mice (second row of images, Fig. 2.8).  
Thus, there was increased apoptosis of epithelial cells in the distal small 
intestines derived from animals lacking ITCH, even without some sort of stress or 
stimulus.   
 Another potential mechanism for more rapid turnover of the epithelium 
would be enhanced homeostatic epithelial cell migration along the crypt-villus 
axis, particularly since this is known to be influenced by proliferation within in the 
small intestinal crypt, wherein an increase or reduction in cell proliferation can 
enhance or slow migration respectively (Parker et al., 2017).  Given the observed 
increase of proliferative cells within the crypts of Itcha18H/a18H animals, we sought 
to evaluate intestinal epithelial cell migration by intraperitoneally injecting twelve 
young adult Itcha18H/a18H and twelve young adult Itch+/+ animals with 100 mg/kg 
BrdU, and three animals of each genotype were euthanized 2, 24, 48 or 72 hours 
post injection.  IHC was performed on sections from the distal small intestines of 
these animals using an anti-BrdU antibody in order to localize the cells that had 
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taken up the BrdU pulse.  As illustrated in Fig. 2.9.A, at 2 hours, all labeled cells 
were contained within the crypts of both ITCH sufficient and ITCH deficient mice.  
By 24 hours following injection, there were distinct differences between the two 
genotypes.  In particular, mice lacking ITCH showed accelerated exodus of the 
label from the proliferating cells in the crypt at 24 hours, increased migration up 
the villus at 48 hours, and nearly complete elimination by 72 hours.  To quantify 
the difference in cell migration along the villus while simultaneously accounting 
for the influence of ITCH on the crypt-villus architecture, a normalized measure of 
cell migration was calculated by dividing the measured length of the furthest 
migrated BrdU+ cell on the villus to the entire length of the villus from 25 well-
oriented villi in at least five different 10x fields per animal and expressed as a 
percentage (Fig. 2.9.B).  Consistent with our qualitative observations, cell 
migration in the Itcha18H/a18H animals was more than double that of the Itch+/+ 
animals at the 24 hour time point (33.46±3.64%, SD, vs. 15.47±4.68%, SD), 
which was statistically significant.  A similar trend was apparent at both the 48 
and 72 hour time points, though the difference between genotypes was not as 
drastic due to the sloughing of cells from the villus tip.  In particular, at 48 hours, 
the edge of the BrdU label front had migrated 58.57±1.91% (SD) up the villus in 
Itcha18H/a18H animals whereas, on average, in Itch+/+ animals, the leading edge 
had not yet reached the midway point (47.15±2.02%, SD).  At 72 hours post 
injection, the BrdU pulse was nearly completely shed in animals lacking ITCH, 
and those labeled cells that remained were at the very tip of the villi 
(97.58±0.09%, SD).  In contrast, in those animals sufficient for ITCH, the vast 
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majority of the labeled cells were present with the farthest migration point being 
90.39±4.36% the length of the villus.  Collectively, our data suggest that 
expansion of the proliferating progenitor cell population leads to accelerated cell 
migration along the crypt-villus axis in Itcha18H/a18H animals.   
 In the small intestine, the intercellular junctions of epithelial cells have 
been noted to be highly dynamic in order to accommodate the rapidly dividing 
tissue while still maintaining tissue integrity (Peglion et al., 2014).  Further, 
alterations in adherens junctions and desmosomes are known to influence cell 
migration in the small intestine (Schneider et al., 2010).  Since Itcha18H/a18H 
animals have increased proliferation and cell migration compared to Itch+/+ 
animals, we hypothesized the cell-cell junctions might be affected in mice lacking 
ITCH.  To test this hypothesis, small intestinal tissues derived from four young 
adult Itcha18H/a18H and four age-matched Itch+/+ mice were examined by 
transmission electron microscopy.  This analysis revealed several differences in 
the ultrastructure of these junctions.  In particular, while tight junctions could be 
readily identified in both Itcha18H/a18H and Itch+/+ derived tissue (Fig. 10, asterisks), 
adherens junctions were less discernable in small intestines derived from 
Itcha18H/a18H  animals (Fig. 10, arrow) and the associated actin cytoskeleton 
appeared to be less organized.  In addition, there was a complete absence of 
desmosomes in the small intestines of Itcha18H/a18H mice (Fig. 10, arrow head).  
Collectively, these data are consistent with a role for ITCH in regulating intestinal 
epithelial turn over. 
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Loss of ITCH significantly decreases intestinal adenoma formation in the small 
intestine of ApcMin/+ animals  
 As the epithelium of the small intestine is under rapid and continuous 
renewal, stringent regulation of epithelial cell turnover is essential to prevent the 
growth of intestinal adenomas (Wong et al., 1996).  In fact, increases in 
homeostatic cell migration have been associated with reduced ApcMin/+ -induced 
tumorigenesis in the small intestine (Sansom et al., 2007).  Since Itcha18H/a18H 
animals have enhanced epithelial cell migration, we hypothesized that loss of Itch 
would decrease intestinal adenoma formation.  To test this hypothesis, the Min 
mutation (ApcMin/+) was moved onto the Itcha18H/a18H background via a two 
generation intercross.  This allowed for polyp assessment in Itch+/+; Apc+/+ (ITCH 
and APC sufficient), Itcha18H/a18H; Apc+/+ (ITCH deficient but APC sufficient), 
Itcha18H/a18H; ApcMin/+ (ITCH deficient and carrying the mutant Apc allele), and 
Itch+/+; ApcMin/+ (ITCH sufficient and carrying the mutant Apc allele) littermates.  
Total polyp number in the small intestines derived from 11 animals of each 
genotype (with approximately equal numbers of males and females) was 
determined when the animals reached 15 weeks of age.  Consistent with 
previous reports (Tucker et al., 2005, 2002) a total of 115.7±52.49 (SD) polyps 
were observed in Itch+/+; ApcMin/+ animals at this age (Fig. 11).  Interestingly, the 
Itcha18H/a18H; ApcMin/+ animals examined had only 27.36±19.62 (SD) polyps (Fig. 
11).  This represents a 76% reduction in tumor burden as compared to the 
Itch+/+;ApcMin/+ cohort, which was statistically significant (p<0.001).  However, the 
number of polyps found in Itcha18H/a18H; ApcMin/+ animals was not statistically 
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different from that of either wild type animals (Itch+/+; Apc+/+) or from animals 
lacking ITCH (Itcha18H/a18H; Apc+/+) as assessed by one-way ANOVA with post 
hoc Tukey correction.  Further, despite the altered cell-cell junctions seen in mice 
lacking ITCH (Fig. 2.10), this accelerated migration appeared to be physiological 
and was not associated with a pathological epithelial to mesenchymal transition 
(EMT) process as EMT markers N-cadherin and vimentin could not be detected 
by western blot on villus protein extracts from either Itch+/+ or Itcha18H/a18H animals 
but were detected in positive controls (heart tissue lysate for N-cadherin and 
HeLa lysate for vimentin, Fig. 2.12).  Thus, as a whole, these data suggest 
increased cell turnover in Itcha18H/a18H mice protects from the initiation of small 
intestinal adenoma formation in ApcMin/+ animals.   
2.5 Discussion	
As a dividing line between self and non-self, the mucosal surface of the 
intestine is essential to maintaining homeostasis, and its breach is associated 
with pathologies like IBD (Mankertz and Schulzke, 2007), chronic viral infections 
(Brenchley et al., 2006; Sandler et al., 2011), and extra-intestinal autoimmune 
diseases such as type 1 diabetes (Wen et al., 2008), rheumatoid arthritis (Wu et 
al., 2010), and multiple sclerosis (Berer et al., 2011; Lee et al., 2011).  However, 
the intestine is far from being a single homogeneous organ; rather, it consists of 
a number of anatomically and functionally specialized segments, each with 
distinct environmental pressures (Agace and McCoy, 2017).  Here, we have 
identified a novel role for the E3 ubiquitin ligase ITCH in the proliferation, 
migration, and differentiation of small intestinal epithelial cells, and, in so doing, 
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offer a putative physiological mechanism for the attenuated inflammatory 
phenotype in the small intestine vs. what has been previously reported in the 
large intestine of animals lacking ITCH (Kathania et al., 2016; Ramon et al., 
2011).  Consistent with those studies, we found little inflammation in the mucosa 
of the small intestine of young adult Itcha18H/a18H mice despite the chronic 
inflammation that is known to accumulate with age at other mucosal surfaces like 
the lungs and skin (C. M. Hustad et al., 1995).  Even though there was a lack of 
inflammatory infiltrate, distinct architectural changes (including villus blunting with 
some cellular disarray, crypt expansion, and thickening of the muscularis propria) 
were present along the length of the small intestine, and these were most 
pronounced in the distal portion.  Many of these same alterations were seen in 
the small intestines of Itcha18H/a18H; Rag1-/- mice which lack a functional lymphoid 
compartment of the immune system.  This suggests that these changes result 
from altered programs in non-hematopoietic cells, in the resident innate immune 
cells, or a combination thereof.   
 Animals lacking ITCH also displayed increased numbers of Paneth and 
goblet cells in the distal small intestine.  Paneth cells are normally only found in 
the small intestinal epithelium and play an important protective role in intestinal 
homeostasis by secreting antimicrobial peptides (Mukherjee et al., 2008; 
Vaishnava et al., 2008).  Further, defects in Paneth cell function have been 
described in IBD patients (Elphick and Mahida, 2005; Wehkamp et al., 2008) as 
well as in a number of mouse lines that develop spontaneous intestinal 
inflammation including Casp8IEC-KO (Günther et al., 2011), FADDIEC-KO (Welz et 
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al., 2011), NEMOIEC-KO (Nenci et al., 2007), and IKK2caIEC-KO (Vlantis et al., 
2011).  While the phenotypes in these lines result from intestinal epithelial-
specific loss of proteins, the effects of Paneth cell function are far from cell 
autonomous as they help shape the microbiome, modulate the mucosal immune 
response, and provide important signaling cues in the intestinal stem cell niche 
(Okumura and Takeda, 2017).  Similarly, the mucins secreted by goblet cells in 
the small and large intestine offer a protective barrier against commensal and 
pathogenic bacterial contact with the immune system.  However, the composition 
of the mucous layer is different in the small and large intestine.  In the former, 
there is a loose, more porous mucus that better facilitates the absorption of 
nutrients and depends on peristaltic actions to propel trapped microbes down the 
digestive tract whereas in the large intestine, the mucus is made of two discrete 
layers (an upper, thinner layer and a thicker lower layer) that has more 
permanence and thus more resident bacteria (Johansson and Hansson, 2016).  
As with defects in Paneth cell function, goblet cell depletion or dysfunction is a 
frequent histopathological feature of IBD (Gersemann et al., 2009).  Thus, 
increased numbers of goblet and Paneth cells in the small intestine of animals 
lacking ITCH may protect it from the more severe inflammation observed in the 
colon.   
 In Itcha18H/a18H mice, increases in Paneth and goblet cells were associated 
with increased proliferation of progenitor cells in the crypt.  It is tempting to 
speculate that either cell intrinsic or local cues promote secretory cell 
specification towards these cells fates.  Differentiation within the secretory cell 
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lineage is highly complex wherein a heterogeneous population of precursors 
exists to direct lineage specification toward enteroendocrine cells or a common 
goblet and Paneth progenitor cell (Basak et al., 2017).  While loss of ITCH was 
associated with an increase in goblet and Paneth cell numbers, enteroendocrine 
lineage specification and maturation appeared unaffected since there were 
equivalent numbers of these cells in the distal small intestine of mice sufficient 
and deficient for ITCH.  Thus, ITCH may influence goblet and Paneth cell 
differentiation downstream of this specification step, potentially through the 
regulation of transcription factors such as SPDEF (Gregorieff et al., 2009).   
 While changes in epithelial differentiation might be driven by epithelial-
intrinsic factors, it is also a formal possibility that they result secondarily from 
signals from the surrounding stroma.  In fact, both mesenchymal and immune 
cells that normally reside in the lamina propria also contribute to intestinal self-
renewal.  Secretion of Hedgehog (Hh) ligands from the epithelium activates this 
signaling pathway within the mesenchyme, which, in turn, can influence intestinal 
homeostasis by altering cell proliferation, differentiation, inflammation, and 
turnover (Buller et al., 2012; Powell et al., 2011).  Interestingly, ITCH has also 
been shown to negativity influence Hh signaling by targeting the downstream 
transcription factor GLI1 (Di Marcotullio et al., 2011), but it remains to be 
determined how loss of ITCH might impact Hh signals in the mesenchyme and 
innate immune system.  In addition to their capacity as potential targets for Hh 
signals, inflammatory cells within the lamina propria can influence epithelial 
homeostasis via the release of proinflammatory cytokines that are capable of 
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feeding back onto the intestinal epithelium to modulate renewal (Garrett et al., 
2010).  Interestingly, ITCH deficient animals have an increase in the mucosal 
production (particularly in the colon) of the proinflammatory cytokines TNF-α, IL-
1β, IL-6, and IL- 17 (Kathania et al., 2016; M. Tao et al., 2009; Theivanthiran et 
al., 2015), which are similarly dysregulated during gastrointestinal inflammation 
and barrier dysfunction (Schenk and Mueller, 2008).  In order to pinpoint the 
initiating signals for the altered intestinal homeostasis observed in ITCH deficient 
mice, future studies employing the recently generated floxed allele of Itch (H. Jin 
et al., 2013) are necessary to delineate the tissue-specific contribution of ITCH in 
the epithelium, immune system, and mesenchyme in isolation from the other 
genes potentially influenced by the a18H inversion to gain important additional 
insight into the multifaceted role ITCH plays in mucosal barrier function. 
 Increased proliferation in the small intestinal crypts of animals lacking 
ITCH was balanced by increased apoptosis at the crypt/villus junction and by the 
enhanced migration and shedding of epithelial cells.  Renewal of the small 
intestinal epithelium is very rapid, and complete epithelial turnover occurs every 
4-5 days (van der Flier and Clevers, 2009).  Turnover in Itcha18H/a18H animals is 
accelerated even further, with approximately 98% of cells being shed from the 
villus after 3 days.  This increased migration correlated with the presence of 
altered cell-cell junctions between intestinal epithelial cells.  In particular, ITCH 
deficient mice lacked desmosomes and had disorganized adherens junctions 
while the tight junctions appeared to remain intact.  Interestingly, E-cadherin, a 
critical component of adherens junctions, has been shown to influence intestinal 
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homeostasis.  Its loss in the intestinal epithelium was associated with altered 
differentiation and maturation of Paneth and goblet cells, induction of cell death, 
loss of adherens junctions and desmosomes, and mislocalization of Paneth cells 
along the crypt-villus axis of the small intestine, and this phenotype was more 
severe in the colonic epithelium despite the fact that more residual E-cadherin 
expression was retained there (Schneider et al., 2010).  Further, overexpression 
of E-cadherin within the intestinal epithelium resulted in suppression of 
proliferation and a reduction in migration along the crypt-villus axis (Hermiston et 
al., 1996).  As mice lacking ITCH still have adherens junctions (albeit 
disorganized ones), it is possible that there might be a slight decrease in E-
cadherin within epithelial cells that is sufficient to contribute to increased 
proliferation, accelerated migration, and increased apoptosis of epithelial cells 
within the small intestine which does not affect maturation programs.  Because of 
the reported disparity in response to loss of E-cadherin between the epithelium of 
the small intestine and that of the colon, it is tempting to speculate that this might 
contribute to the different inflammatory profiles of the small and large intestine in 
Itcha18H/a18H mice. 
 Further evidence that homeostasis is more appropriately regulated in the 
small  intestine than in the colon of mice lacking ITCH comes from our 
observation that Itcha18H/a18H; ApcMin/+ animals had a 76% reduced tumor load as 
compared to Itch+/+; ApcMin/+ littermates (Fig. 7), whereas ITCH deficient mice 
have been reported to be more susceptible to the induction of colitis-associated 
cancer which develops in the context of chronic inflammation of the colon 
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(Kathania et al., 2016).  This likely reflects, in part, the different initiating events in 
these types of tumors.  Specifically, while the ApcMin/+ mouse more closely 
parallels what occurs in sporadic colon cancers where there is a sequential 
accumulation of genetic mutations that promotes a progressively more malignant 
phenotype in what has been dubbed the “adenoma-carcinoma sequence” (Cho 
and Vogelstein, 1992), colitis associated cancer is driven by the activation of 
completely different pathways, usually without constitutive activation of the APC-
β-catenin-TCF axis (Foersch and Neurath, 2014).  Furthermore, the increased 
cell turnover in the small intestine of ITCH deficient animals potentially 
contributes to the decrease in adenoma initiation observed in Itcha18H/a18H; 
ApcMin/+ mice.  Previous studies have shown that increased homeostatic 
epithelial migration was associated with reduced ApcMin/+ -induced tumorigenesis 
in the small intestine (Sansom et al., 2007), suggesting that perturbations in the 
intestinal epithelial cell migration observed in Itcha18H/a18H mice potentially 
influence intestinal adenoma formation by limiting the anchorage of cancer-
initiating cells needed for adenoma induction and growth.  However, there was 
no evidence that animals lacking ITCH had a switch from E-cadherin to N-
cadherin expression which is observed in EMT and promotes the invasive 
capabilities of cancer cells (Halbleib and Nelson, 2006), though this possibility 
needs to be more thoroughly evaluated in a more aggressive colorectal cancer 
model than the ApcMin/+  mouse because the tumors in those animals rarely 
become invasive (Nalbantoglu et al., 2016).   
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 In conclusion, the differences observed in the homeostasis of the intestinal 
epithelium of the small vs. the large intestines in Itcha18H/a18H animals provide 
physiological insight into regional specificities of these segments of the 
gastrointestinal tract.  Further studies aimed at defining the molecular pathways 
downstream of ITCH and determining whether the phenotype of the Itcha18H/a18H 
small intestine resembles that of “mucosal healing” in IBD following the 
abatement of inflammation may allow for the identification of novel biomarkers 
associated with long-term remission and low risk of surgical treatment in IBD as 
well as potential new avenues for therapeutic intervention. 
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2.6 Figures  
 
Figure 2.1.  Itcha18H/a18H intestines have increased rostral-to-caudal length 
and decreased circumference.  The entire length of the small intestine from 9 
week old Itch+/+ (n=12) and Itcha18H/a18H (n=12) animals were removed and the 
length along the x-axis was measured in cm.  Itcha18h/a18H small intestines are 
significantly longer (***p<0.001) than Itch+/+ animals.  The proximal, middle, and 
distal segments from the small intestine of 9-week old Itch+/+ (n=10) and 
Itcha18H/a18H (n=10) were opened longitudinally to quantify the width of the small 
intestine in mm.  The small intestine from Itcha18H/a18H animals had a significantly 
shorter width proximally (**p<0.005), middle (**p<0.005), and distally (*p<0.05) 
when compared to Itch+/+ animals.  
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Figure 2.2.  Small intestinal architecture is altered in Itcha18H/a18H animals.  
(A)  Representative H&E stained paraffin-embedded small intestinal sections 
derived from the proximal (left most column), middle (center column), and 
distal (right hand column) segments of young adult Itch+/+ and Itcha18H/a18H 
animals accentuate an enlargement of the intestinal crypt in Itcha18H/a18H 
animals, becoming more pronounced distally.  Scale bars = 200 µm.  (B) Small 
intestinal crypt and villus areas from young adult Itch+/+ (n = 4 or 5) and 
Itcha18H/a18H (n = 5) were measured in µm2 using ImageJ.  A minimum of 25 
well-orientated crypts or villi from at least seven different 10x fields were 
measured per animal.  Average crypt area was significantly increased 
(*p<0.005) in the middle and distal small intestine of Itcha18H/a18H compared to 
Itch+/+.  (C) Average villus area was significantly increased (*p<0.05) distally in 
the small intestine of Itcha18H/a18H animals compared to Itch+/+.  
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Figure 2.3.  Small intestinal architectural changes observed in ITCH 
deficient mice are lymphoid independent.  Representative H&E stained 
paraffin-embedded distal small intestinal sections from 12 week old Itch+/+; 
Rag1+/+ (wild type, far left), Itch+/+; Rag1-/- (RAG1 deficient, middle left), 
Itcha18H/a18H; Rag1-/- (RAG1 and ITCH deficient, middle right), and 
Itcha18H/a18H; Rag1+/+ (ITCH deficient, far right) animals are shown.  Animals 
lacking both ITCH and RAG1 produce no functional lymphocytes, yet still 
develop crypt hyperplasia (height of bracketed bar), villus blunting, and 
expansion of the muscularis propria (asterisk), suggesting that these 
phenotypes arise as a consequence of signals produced by epithelial and/or 
resident innate immune cells.  However, the cellular disorganization seen in 
Itcha18H/a18H; Rag1+/+ animals was not observed in Itcha18H/a18H; Rag1-/-  mice.  
Scale bars = 100 µm.  Magnification= 20x.   
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Figure 2.4.  Alterations in Itcha18H/a18H crypt morphology 
is reflective of increased total cell numbers within the 
crypt.  Total cell numbers within the crypt were manually 
counted from paraffin-embedded adult Itch+/+ and 
Itcha18H/a18H intestinal sections immunostained for Ki67 and 
counterstained with hematoxylin.  The average total cell 
number within the crypts were assessed by counting the 
total number of cells from 25 well-oriented crypts in a 
minimum of nine different 20x fields from each adult Itch+/+ 
(n = 5) or Itcha18H/a18H (n = 5) animal.  Itcha18H/a18H animals 
had a statistically significant increase (49.46±6.03, SD) in 
total cell number (*p<0.005) within the crypt compared to 
Itch+/+ animals (35.90±34.86, SD) when analyzed by a 2-





Figure 2.5.  Crypt expansion in Itcha18H/a18H animals is accompanied by an 
increase in proliferating TA cells and differentiated Paneth cells.  (A) 
Pictured are representative micrographs of IHC performed on paraffin-
embedded distal intestinal sections derived from young adult Itch+/+ and 
Itcha18H/a18H animals (n = 5 for each genotype) using an anti-Ki67 antibody and 
subsequently counterstained with hematoxylin.  Animals lacking ITCH appear to 
have increased cellular proliferation in the crypt.  Scale bars = 50 µm.  (B) 
Average number and average percentage of Ki67+ cells in the crypts from adult 
Itch+/+ (n = 5) and Itcha18H/a18H (n = 5) animals.  Ki67+ cells and total cell numbers 
were counted from 25 well-oriented crypts in a minimum of nine different 20x 
fields per animal. Itcha18H/a18H animals had, on average, 13 more Ki67+ cells per 
crypt which was statistically significant (*p<0.01).  No difference was observed in 
the percentage of proliferating cells within the crypt.  Error bars represent SD.  
(C) Representative phase contrast-coupled immunofluorescent images of 
paraffin-embedded sections of distal intestine from five adult Itch+/+ and five age-
matched Itcha18H/a18H animals stained with anti-lysozyme (red) and DAPI (blue). 
Scale bars = 100 µm.  (D) Average number of Paneth cells per crypt from adult 
Itch+/+ (n = 5) and Itcha18H/a18H (n = 5) animals.  Paneth cells from 30 crypts in a 
minimum of 12 different 20x fields were averaged to determine that Itcha18H/a18H 
animals have significantly more Paneth cells (*p<0.05) than Itch+/+ animals.  
Error bars represent SEM.
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Figure 2.6.  Loss of ITCH promotes goblet cell differentiation.  (A) Paraffin-
embedded intestinal sections stained with alcian blue, pH 2.5 and counterstained 
with nuclear fast red distinguish goblet cells from adult Itch+/+ and Itcha18H/a18H 
animals. Scale bars = 200 µm.  (B) Pictured are representative Itch+/+ and 
Itcha18H/a18H derived paraffin-embedded sections stained with 1% silver nitrate to 
identify enteroendocrine cells in the small intestine. Scale bars = 200 µm.  (C) 
Paraffin-embedded sections stained with AP highlights the brush boarder of 
enterocytes on the villi of Itch+/+ and Itcha18H/a18H animals. Scale bars = 200 µm.  
(D) Average number of goblet cells, enteroendorcine cells, and enterocytes 
located on the villus of Itch+/+ (n = 4) and Itcha18H/a18H (n = 4) animals.  Indicated 
type of cells were counted on 30 villus structures from a minimum of eight 
different 10x fields per animal.  Enteroendocrine cell counts are presented as a 
histogram of the total number of villus structures bearing no, one, two or three 
cells in Itch+/+ (n = 4) and Itcha18H/a18H (n = 4) animals.  Itcha18H/a18H animals have a 
statistically significant increase (*p<0.05) in goblet cells. There was no 
statistically significant difference in enteroendocrine or enterocyte cell number.  
Error bars represent SEM for goblet cell counts.    
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Figure 2.7.  Loss of ITCH influences specification without altering total 
epithelial cell numbers on the villus.  Average total epithelial cell number on 
the villus was determined by adding the means from enterocytes, goblet cells, 
and enteroendocrine cells that were counted on 25 to 30 separate villus 
structures in a minimum of eight different 10x fields from each adult Itch+/+ (n = 4) 
or Itcha18H/a18H (n = 4) animal.  To determine significance, the mean total cell villus 
numbers from adult Itch+/+ (n = 4) or Itcha18H/a18H (n = 4) animals were compared 
using a 2-tailed, unpaired t-test, which showed no statically significant difference 
between the Itch+/+ and Itcha18H/a18H groups (62.04±3.43, SD versus 59.45±5.18, 
SD).  Error bars represent SD of total cell number.   
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Figure 2.8.  Loss of ITCH promotes epithelial apoptosis in 
the small intestine.  Paraffin embedded sections from the 
distal small intestine of young adult Itch+/+ and Itcha18H/a18H 
animals (n = 4 for each genotype) were immunostained for 
cleaved-caspase 3 and counterstained with hematoxylin.  
Representative photomicrographs are shown.  While rare 
apoptotic cells could be found at the tips of villi in animals of 
both genotypes (arrowheads, top row of micrographs), 
increased apoptosis was seen at the crypt-villus junctions in 
only those animals lacking ITCH (bottom row, 63x).  Scale 





Figure 2.9.  Epithelial turnover is increased in animals that lack ITCH.  (A) 
IHC with an anti-BrdU antibody was conducted on paraffin-embedded sections 
obtained from young adult Itch+/+ and Itcha18H/a18H animals intraperitoneally 
injected with 100mg/kg of BrdU.  Brightfield images were taken 2, 24, 48, and 72 
hours post injection and representative examples from each genotype and time 
point were converted to spectral images using the lookup tables available in 
ImageJ as seen here.  These images demonstrate enhanced migration of 
epithelial cells in Itcha18H/a18H animals with complete sloughing by 72 hours 
following the BrdU pulse.  Scale bars = 200µm. (B) Average cell migration of 
BrdU-labeled cells along the villus axis in Itch+/+ (n = 3) and Itcha18H/a18H (n = 3) 
animals at 24, 48, and 72 hours after BrdU incorporation was calculated by 
dividing the measured distance of the furthest migrated labeled cell from the 
base of the villus by the entire length of the villus from 25 villi in a minimum of 
five different 10x fields per animal.  Since all cells were localized to the crypt in 
both genotypes at the 2-hour timepoint, this data point is not shown.  A 
statistically significant increase in cell migration at was detected in Itcha18H/a18H 
derived tissues at 24 (**p<0.005), 48 (**p<0.005), and 72 hours (*p<0.05) versus 




Figure 2.10.  Itcha18H/a18H animals have altered cell-cell 
junctions.  Representative transmission electron 
micrographs of cell-cell junctions (tight junctions marked by 
asterisks, adherens junctions by arrows, and desmosomes by 
arrow head) from the proximal small intestine of nine week-
old Itch+/+ and Itcha18H/a18H animals are depicted here.  In total 
samples from 4 animals of each genotype were examined.  
Itcha18H/18H animals lack identifiable desmosomes and 
adherens junctions appeared more disorganized than the 




Figure 2.11.  Loss of ITCH is protective in ApcMin/+ 
tumorigenesis.  Polyps from the small intestine of 15 week-old 
Itch+/+; Apc+/+ (n = 11), Itcha18H/a18H; Apc+/+ (n = 11), Itch+/+; ApcMin/+ 
(n = 11), and Itcha18H/a18H; ApcMin/+ (n = 11) animals were 
visualized by staining the flushed and fixed small intestine with 
0.1% methylene blue.  Polyps from the entire length of the 
intestine were counted under a dissecting scope.  The graph 
shown here depicts the average number of small intestinal polyps 
per animal.  Itcha18H/a18H; ApcMin/+ animals were observed to have 
a significant reduction in tumor burden compared to Itch+/+; 
ApcMin/+ littermates (*p<0.001, NS = not significant).  Error bars 
represent SD.   
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Figure 2.12.  Loss of ITCH promotes epithelial migration without 
leading to an epithelial-to-mesenchymal transition (EMT).  40 µg 
of protein lysate isolated from the villi of Itch+/+ (n = 6) and Itcha18H/a18H 
(n = 8) animals separated by SDS-PAGE was transferred to a PVDF 
membrane prior to immunblotting for ITCH, N-cadherin, Vimentin and 
GAPDH.  Protein lysate from HeLa cells or murine heart was used as 
a positive control for markers of EMT.  As expected, protein derived 
from ITCH deficient animals expressed no ITCH protein (arrow in top 
panel) while all samples expressed GAPDH.  EMT markers N-
cadherin or Vimentin could not be detected in either Itch+/+ or in 
Itcha18H/a18H villus lysates, indicating that loss of ITCH in the small 
intestine likely does not promote EMT.  Each lane represents one 




INTESTINAL MUCOSAL HOMEOSTASIS IS DEPENDENT ON THE TISSUE 
SPECIFIC FUNCTIONS OF ITCH IN BOTH THE EPITHELIUM AND IMMUNE 
SYSTEM  
3.1 Introduction  
 With the advent of new extracellular matrices, in combination with the 
identification of the Lgr5+ intestinal stem cell population, the ability to culture 3-
dimensonal (3D) epithelial organoids ex vivo without the surrounding stroma 
recently became an actuality (T. Sato and Clevers, 2013).  Through the years, 
the term “organoid” has evolved from its originally meaning, which was 
synonymous with oncogenic teratomas, to its current form being defined as the 
growth of ex vivo structures from pluripotent stem cells or tissue-specific adult 
stem cells that adopt a near native 3-D architecture reminiscent of the tissue 
architecture in vivo.  In the presence of growth factors and morphogens specific 
to the intestinal stem cell niche, single crypts isolated from the small intestine can 
develop and grow into small intestinal organoids.  These 3-D “mini guts” form a 
highly stereotypical layout wherein a continuous layer of cells is organized into a 
central, spherical lumen surrounded by a monolayer of differentiated epithelial 
cells that arise from the highly proliferative budding structures that jut outward 
from the central lumen (T. Sato and Clevers, 2013).  Consistent with the 
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definition of “organoid”, the intestinal organoids (or enteroids) reconstitute the 
intestinal epithelial architecture in the absence of the mesenchyme.  The base of 
the budding structure in the organoid houses the Lgr5+ stem cell population and 
differentiated Paneth cells, similar to the anatomy of the in vivo intestinal crypt.  
As the stem cells divide, the progeny migrate along the bud to give rise to the 
transit-amplifying population, which continue to migrate eventually differentiating 
into epithelial post-mitotic cells that will line the central lumen.  At the end of the 
differentiated cell’s lifespan, the apoptotic cell will be sloughed off in to the lumen 
where it will remain indefinitely (Grabinger et al., 2014), in contrast to what 
occurs in vivo, wherein the continual peristaltic motion and passage of chyme 
eliminate the extruded epithelial cells.  Thus, in the 3-D intestinal organoid 
system, all apoptotic cells that have been discarded from the inception of the 
organoid can be quantified, making it a more accurate measure of apoptosis 
compared to in vivo, which relies on capturing a “snap-shot” of a continual 
process via pro-apoptotic markers as a surrogate for cell death.  
 The continued growth and expansion of the enteroid is promoted by the 
enormous self-renewal capacity of the Lgr5+ intestinal stem cell population that 
resides in the budding structures, thereby providing a proxy to assess the 
regenerative capacity of the intestinal organoid ex vivo (Kretzschmar and 
Clevers, 2016).  Growth of the spherical organoid into a mature mini-gut is 
initiated by the formation of a bud, which occurs at a location where intestinal 
stem cells and Paneth cells are both present.  The proliferative stem cell 
population surrounded by the WNT-producing Paneth cells propels itself outward 
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to initiate a bud, likely mediated by the repulsive forces established from the 
EphB-EphrinB gradient that is influenced by WNT signaling (Batlle et al., 2002a; 
T. Sato and Clevers, 2013).  In vivo, as progenitor cells migrate down the WNT 
gradient, they differentiate and slowly replace EphBs with EphrinBs, which 
establishes the crypt-villus boundary and the proper positioning of cells (Fig.3.1). 
It is thought that similar signaling pathways operate ex vivo (T. Sato and Clevers, 
2013).  Once mature crypts are formed in the enteroid, the continued growth and 
expansion of crypts is driven by crypt fission, a process that increases crypt 
number through the bifurcation of a crypt into two daughter crypts (Baker et al., 
2014).  While this homeostatic process occurs in vivo at a fairly low basal rate, 
the destruction of the crypt by chemical, immunological, or radiological means, 
exponentially increases crypt fission to promote tissue regeneration (Pin et al., 
2015).  Postnatally, crypt fission is also increased to expand the existing 
population of crypts to generate the appropriate number required to preserve 
intestinal homeostasis in the adult.  Though the mechanisms driving this process 
remain unclear, it has been postulated that the mechanical forces from the 
underlying mucosa, which establishes a buckle at the base of the crypt to 
promote crypt division, are influenced by the spatial orientation of both Lgr5+ 
stem cells and Paneth cells in the crypt (Langlands et al., 2016; Pin et al., 2015).  
Thus, the importance of stem and Paneth cell numbers as well as their spatial 
distribution appear paramount in driving this process.  
 Previously, we showed that global loss of the E3 ligase ITCH (Itcha18H/a18H) 
alters intestinal epithelial homeostasis by promoting intestinal epithelial cell 
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proliferation, secretory cell differentiation, and migration, which could be intrinsic 
to the epithelium (Chapter 2).  However, since ITCH is known to have important 
functions within the immune system (Aki et al., 2015), in combination with the 
high level of interplay between the epithelium and the immune system in the 
small intestine (Vindigni et al., 2016), loss of ITCH in this compartment likely 
contributes the epithelial defects observed in the Itcha18H/a18H animals.  
Interestingly, the potential dual role of ITCH in both the epithelium and immune 
system is comparable to the complex role described for NFκB signaling in the 
small intestine (Wullaert et al., 2011).  While activation of this pathway within the 
immune system promotes intestinal epithelial inflammation and altered intestinal 
homeostasis, NFκB is required in the epithelium to limit the response of the 
immune system (M. F. Tao et al., 2009; Wullaert et al., 2011).  To this end, we 
hypothesize that loss of ITCH in the epithelium and immune compartment plays a 
dual role in promoting intestinal mucosal inflammation that leads to altered 
intestinal homeostasis.  
 To identify whether an intrinsic function for ITCH exists in the intestinal 
epithelium independent of the influence of the immune compartment, small 
intestinal organoids sufficient and deficient for ITCH were established.  
Surprisingly, a significant decrease in both the number of nonbudding organoids 
and in the average number of buds (in those colonies that do bud) was observed 
in ITCH deficient as compared to ITCH sufficient isolates.  Despite the defects in 
budding observed in organoids lacking ITCH, comparable numbers of intestinal 
Lgr5+ stem cells were present in the organoids sufficient and deficient for ITCH.  
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Further, proliferation and cell differentiation were not perturbed in ITCH deficient 
enteroids, in contrast to the in vivo phenotype of the Itcha18H/a18H small intestines 
(Chapter 2).  However, increased apoptosis was observed in enteroids lacking 
ITCH, which was also detected in mice lacking ITCH in only the intestinal 
epithelium, thus identifying an epithelial specific role for ITCH in the intestine.  
Interestingly, at six months of age, animals with a myeloid-specific loss of ITCH 
(Itchfl/fl; LysMCre/Cre), displayed alterations in the epithelial architecture similar to 
those seen in two month old mice constitutively lacking ITCH (Chapter 2).  Thus, 
the delay in the presentation of this phenotype in Itchfl/fl; LysMCre/Cre animals 
highlights a potential synergistic role for ITCH in the intestinal epithelium and in 
the immune system to fine-tune mucosal immune responses and maintain 
homeostasis.   
3.2 Materials and Methods 
Animals 
 Animals homozygous for a null allele of Itch (Itcha18H/a18H) have been 
previously described (Hustad et al., 1995).  For developmental staging, the 
day a copulatory plug was detected was designated E0.5 while the date of 
birth was considered P0. 
To generate Itcha18H/a18H animals in which intestinal stem cells were 
labeled with eGFP (B6.129P2-Lgr5tm1(cre/ERT2)Cle/J, stock #008875, hereafter 
referred to as Lgr5eGFP/+), Itcha18H/a18H mice were bred to Lgr5eGFP/+ animals to 
produce Itcha18H/+; Lgr5eGFP/+ and Itcha18H/+; Lgr5+/+ offspring.  Subsequently, 
Itcha18H/+; Lgr5eGFP/+ mice were backcrossed to Itcha18H/a18H animals to produce 
Itcha18H/a18H; Lgr5eGFP/+ animals used for analysis.  Controls animals (Itch+/+; 
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Lgr5eGFP/+) for age-matched male and female Itcha18H/a18H; Lgr5eGFP/+ mice were 
obtained from the original Lgr5eGFP/+ line used to establish the Itcha18H/a18H ; 
Lgr5eGFP/+ colony.  To generate mice lacking Itch in the myeloid cell lineage, 
animals heterozygous for a floxed Itch allele (Fig.3.2) were bred to LysMCre/Cre 
animals (JAX stock #004781).  A series of intercrosses and backcrosses were 
performed to generate Itchfl/fl; LysMCre/Cre animals.  Age-matched animals from 
C57BL/6J or Itchfl/fl; LysM+/+ animals were used as experimental controls and 
are designed as wild-type (WT) in the indicated experiment.  A similar 
breeding scheme using VillinCre/Cre animals was applied to generate animals 
lacking Itch in the intestinal epithelium (Itchfl/fl; VillinCre/+).  All experiments were 
conducted in full compliance with the Institutional Animal Care and Use 
Committee of the University of South Carolina or the University of Central 
Florida. 
Establishment of Murine Small Intestinal Organoids 
 Small intestinal organoids were established from 9-11 week old Itch+/+; 
Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ animals.  To establish a single isolate of 
intestinal organoids, approximately 10 cm from the most proximal segment of the 
small intestines from two age-, gender- and genotype-matched animals were 
placed in a petri dish containing 10 mL of ice-cold Dulbecco’s PBS (DPBS, 
Corning, # 21-031-CV).  Before flushing the small intestine with 1 mL of DPBS, 
the tissue was cut into 2 equal size segments to facilitate the removal of the 
luminal content.  Flushing of the small intestine was performed 3 times before 
longitudinally opening the small intestine and transferring the tissue to a new 
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petri dish containing 5 mL of DPBS.  To remove any residual waste, the small 
intestinal segments were gently agitated before cutting them into 2 mm size 
pieces that were collected in a 50 mL conical tube containing 15 mL of fresh, ice-
cold DPBS.  To isolate crypts, the small intestinal pieces were placed on ice 
before pipetting all intestinal pieces up and down in 12 mL of fresh, ice-cold 
DPBS three times using a 10 mL pipet.  Once the tissue settled to the bottom of 
the tube, the supernatant was carefully removed using a 10 mL pipet.  This 
process was repeated 14 times with fresh, ice-cold DPBS to gently remove 
debris as well as villi before placing the tissue in 25 mL of Gentle Cell 
Dissociation Buffer (25°C) (Stem Cell Technologies # 07174) on a rocking 
platform at 20 rpm for 15 minutes at 25°C.  The tissue was placed back on ice to 
allow the intestinal pieces to settle to the bottom of the tube.  At that time, the 
Gentle Cell Dissociation Buffer was removed and the cells were resuspended in 
10 mL of ice-cold DPBS supplemented with 0.1% fetal bovine serum.  The 
intestinal tissue was pipetted up and down three times to dissociate intestinal 
crypts from the tissue prior to removing and filtering the supernatant through a 70 
µm filter, which was labeled as Fraction 1.  This process was repeated with three 
additional 10 mL aliquots of ice-cold DPBS plus 0.1% fetal bovine serum was to 
generate Fractions 2-4.  Once all four fractions were collected, the supernatant 
was centrifuged at 290 x g for 5 minutes at 4°C.  The supernatant was decanted 
and the pellet was resuspended in 10 mL of ice-cold DPBS supplemented with 
0.1% fetal bovine serum.  To assess the quality of the crypt isolation, 1 mL from 
each fraction was placed in an individual well of a 6-well plate and crypt 
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enrichment was ascertained using bright-field microscopy.  The two fractions with 
the highest crypt-to-cell debris ratio were selected (usually fractions 3 and 4) to 
carry out the remaining steps.  Before centrifuging the 2 selected fractions at 200 
x g for 3 minutes at 4°C, the 1 mL used to assess crypt quality was returned to 
the appropriate fraction.  After centrifugation, the supernatant was decanted and 
the pellets were resuspended in 10 mL of ice-cold Dulbecco’s Modification of 
Eagle’s Medium (DMEM)/Ham’s F-12 50/50 media (Corning, # 21-031-CV) each.  
To determine total crypt number, 10 µL of each fraction was placed in a 
hemacytometer, and the total number of crypts was quantified.  A total of 3,000 
crypts were transferred to a new tube and supplemented with DMEM/Ham’s F-12 
50/50 media to produce a final volume of 10 mL.  After centrifuging the crypts at 
200 x g for 5 minutes at 4°C, the media was gently removed using a pipet and 
the crypts were resuspended in 150 µL of pre-warmed IntestiCult organoid 
growth media (Stem Cell Technologies, #06005) followed by 150 µL of matrigel 
(Corning #356234) that had been thawed on ice.  Crypts were plated in 50 µL 
drops into a pre-warmed 24-well plate and placed in an incubator at 37°C/5% 
CO2 for a minimum of 10 minutes to allow the matrigel to solidify before adding 
750 µL of pre-warmed organoid growth media to each well.  Media was changed 
every 2-3 days and organoid plugs were passaged every 6-9 days (as described 
below) to allow for optimal growth conditions.  All organoids were passaged at 
least twice before being used in the indicated experiments to mitigate the 
contribution of the surrounding stroma on the epithelium.  A total of 2 isolates (1 
male and 1 female) from Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ animals 
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were used for all intestinal organoid experiments with the exception of the 
intestinal budding experiments in which 3 isolates (2 male, and 1 female) per 
genotype were used for quantification. 
Passaging of Intestinal Organoids 
 Organoid growth media from 5-9 day old organoids was removed and 1 
mL of ice-cold Gentle Cell Dissociation Buffer was placed in each well to be 
passaged for 1 minute at room temperature.  The matrigel plug was gently 
pipetted up and down 20 times to disassociate the pellet before placing it in a 15 
mL conical tube.  Each well was washed with 1 mL of the gentle dissociation 
buffer and collected in the appropriate 15 mL conical tube.  Disassociation of the 
organoids was accomplished by placing organoids on a rocking platform at 20 
rpm for 10 minutes at 25°C before centrifugation at 290 x g for 5 minutes at 4°C.  
The supernatant was decanted and the organoids were resuspended in 10 mL of 
DMEM/Ham’s F-12 50/50 media prior to centrifuging at 200 x g for 5 minutes at 
4°C.  The supernatant was gently removed using a pipet, and the organoids were 
resuspended at a 1:1 ratio in pre-warmed organoid growth media followed by the 
addition of matrigel that had been thawed on ice using a volume sufficient for the 
proper split according to density of the culture (i.e., 1:3 to 1:6).  Organoids were 
plated in 50 µL drops into a pre-warmed 24-well plate and placed in an incubator 
at 37°C/5% CO2 for a minimum of 10 minutes to allow the matrigel to solidify 
before adding 750 µL of pre-warmed organoid growth media to each well.  
Organoids used for the experiments described here were passaged a minimum 
of 3 times prior to analysis but no more than eight times total. 
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Quantification of Intestinal Organoid Budding 
 Three isolates for age- and gender-matched Itch+/+; Lgr5eGFP/+ (n = 3, 2 
male-derived and 1 female-derived isolates) and Itcha18H/a18H; Lgr5eGFP/+ (n = 3, 2 
male-derived and 1 female-derived isolates) were seeded in triplicate, and 
numbers of nonbudding versus budding organoids were quantified from a 
minimum of eight 10x phase contrast images acquired on a Leica DMI6000B 
microscope equipped with a Hamamatsu ORCA-R2 CCD camera.  To assess 
significance, a chi-squared analysis of a 2x2 contingency table was performed 
and plotted using Prism software (GraphPad Software, Inc). 
Intestinal Organoid Growth Characterization 
 Two independent age- and gender-matched isolates from each 
genotype (consisting of 1 male-derived and 1 female-derived isolate) were 
seeded in duplicate on a 4-chambered slide, and growth was monitored by 
phase-contrast microscopy.  Specifically, images were acquired one, three and 
five days following plating for all 8 matrigel plugs.  Day 1 images were 
acquired using a 40x objective while day 3 and day 5 images were acquired 
using a 20x objective on a Leica DMI6000B microscope equipped with a 
Hamamatsu ORCA-R2 CCD camera. 
Sample Prep Fluorescent Confocal Microscopy 
 To obtain frozen sections, organoid growth media from five to six day 
intestinal organoids was removed and replaced with 1 mL of ice-cold DPBS for 1 
minute before gently disassociating the plug mechanically by pipetting up and 
down.  Organoids were placed in a 1.5 mL microfuge tube and centrifuged at 100 
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x g for 1 minute at 4°C to pellet organoids.  The intestinal organoids were 
resuspended in 4% PFA and fixed for 20 minutes at 25°C. To remove PFA, 
organoids were centrifuged at 100 x g for 1 minute at 4°C and resuspended in 1 
mL of PBS.  Organoids were centrifuged as above a total of three times. To 
facilitate visualization of the organoids, the organoids were incubated with 250 µL 
Alcian Blue, pH 2.5 for a minimum of 5 minutes, but not longer than 20 minutes, 
centrifuged (100 x g for 1 minute at 4°C), and resuspended in 1 mL PBS.  
Organoids were washed as previously described a total of three times before 
cryoprotecting the organoids by incubating them sequentially in a 15% and 30% 
sucrose/PBS solution at 4°C in each solution for a day.  The organoids were 
washed once in PBS before embedding the samples in Optimal Cutting 
Temperature (OCT) compound and freezing in an 100% ethanol:dry ice bath.  To 
embed organoids in OCT compound, the enteroids were resuspended in 
approximately 30 µL of PBS and transferred to the center of a mold before 
forming a circular well surrounding the organoids with OCT compound.  The 
remaining mold was filled with OCT compound to the desired level. 40 µm thick 
frozen sections were brought to 25°C before being post-fixed in 4% PFA for 10 
minutes.  The PFA was removed and the samples were allowed to air dry for 10 
minutes at 25°C before 3 sequential washes in PBS for 3 minutes each.  The 
samples were blocked for 1 hour in a solution containing 10% normal goat 
serum, 2% bovine serum albumin, and 0.2% Triton X-100 in PBS. The primary 
antibodies Chromogranin A (C-12, Santa Cruz, 1:200) and Lysozyme (RP028, 
Diagnostic BioSystems, 1:100) were diluted in PBS containing 1% normal goat 
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serum and 0.1% Triton X-100 and incubated on sections in a humidified chamber 
overnight at 4°C. Before incubation with the appropriate secondary antibody, the 
samples were washed 3 times in PBS for 3 minutes each wash.  AlexaFluor659-
conjugated goat anti-mouse secondary (Jackson ImmunoResearch, 1:500) or 
Cy3-conjugation goat anti-rabbit secondary (1:200) was applied for an hour 
before mounting sections in ProLong Gold Antifade Mountant with DAPI 
(P36931, Molecular Probes).  To identify goblet cells, 40 µm frozen sections that 
were post-fixed in 4% PFA for 10 minutes were mounted in ProLong Gold 
Antifade Mountant (P36930, Molecular Probes) and DIC images were acquired to 
identify goblet cells by morphology.  DIC coupled fluorescent images and DIC 
images were acquired on a Leica SP8X confocal microscope equipped with HyD 
detectors and conventional photomultiplier tubes (PMTs). 
 Visualization of endogenous eGFP-marked Lgr5+ stem cells was carried 
out using whole mount intestinal organoids fixed in 4% PFA for 20 minutes at 
25°C after isolation of intestinal organoids from the matrigel as above. Samples 
were incubated in block containing 10% normal goat serum, 2% bovine serum 
albumin, and 0.2% Triton X-100 in PBS for 1 hour before mounting whole 
organoids in ProLong Gold Antifade Mountant with DAPI (P36931, Molecular 
Probes).  40x fluorescent images were acquired on a Leica SP8X confocal 
microscope equipped with HyD detectors and conventional PMTs. 
EdU Incorporation in Intestinal Organoids 
Two independent intestinal organoid isolates (1 male and 1 female) for 
both Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ genotypes were seeded in 
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triplicate in a 4-chamber slide, and, six days later, 10 µM EdU was applied to 
each plug for 1 hour at 37°C.  Upon removal of EdU supplemented media, the 
organoids were washed in DPBS at 25°C for 3 minutes, which was repeated an 
additional 2 times.  The organoids were fixed in 4% PFA for 20 minutes at 25°C 
and washed in DPBS at 25°C, three times for three minutes each wash. Samples 
were blocked for 1 hour at 25°C before applying the Click-IT reaction cocktail 
contained in Click-IT AlexuFluor Kit (ThermoFisher Scientific, C10337) 
supplemented with an AlexaFluor 594 Azide anitbody (ThermoFisher Scientific, 
A10270).  The Click-IT reaction cocktail was applied to the organoids for 30 
minutes at 25°C in the dark.  The samples were washed twice for two minutes 
each wash in PBS before applying DAPI (Invitrogen, C10457, 1:2000) diluted in 
PBS for 10 minutes at 25°C.  Prior to mounting (50% glycerol/50% PBS medium) 
the organoids contained within the 4-chambered slides, the organoids were 
washed once in PBS for 5 minutes. Fluorescent images were acquired on a 
Leica SP8X confocal microscope equipped with HyD detectors and conventional 
photomultiplier tubes (PMTs). 
Propridum Iodide (PI) Staining 
 Two isolates of age- and gender- matched Itch+/+; Lgr5eGFP/+ (1 male and 1 
female isolate) and Itcha18H/a18H; Lgr5eGFP/+ (1 male and 1 female isolate) intestinal 
organoids were seeded in duplicate in a 4-chamber slide, and, four days later, 
intestinal oragnoids were incubated with 100 µg/mL propridium iodide (PI) 
(Sigma, stock #81845) for 30 minutes at 37°C/5%CO2.  Organoids were washed 
three times with pre-warmed DPBS before placing 750 µL of pre-warmed 
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DMEM/Ham’s F-12 50/50 media on the matrigel plugs.  Phase contrast-coupled 
fluorescent images were acquired on a Leica DMI6000B epifluorescence 
microscope equipped with a Hamamatsu ORCA-R2 CCD camera.  Quantification 
of fluorescent and organoid surface area was measured using ImageJ software 
from eight 10x images from each matrigel plug.  A total of 94 and 84 organoids 
were counted for ITCH sufficient and deficient organoids, respectively.  An 
unpaired, two-tailed student t-test was used to assess significance. 
Immunohistochemistry 	
Paraffin sections (4-6 µm) from the distal small intestine of Itchfl/fl ; 
VillinCre/+ and WT controls were subjected to IHC.  In particular, antigen 
unmasking was performed using 10 mM Tris-HCl/ 1 mM EDTA, pH=9 for 30 
minutes at 95°C.  Subsequently, slides were cooled for 1 hour at 25°C in the 
antigen unmasking solution before being washed three times in PBS for three 
minutes each.  Sections were blocked in a solution containing 10% normal goat 
serum, 2% bovine serum albumin, and 0.2% Triton X-100 in PBS.  An additional 
hydrogen peroxidase block (50% hydrogen peroxide of a 3% solution) / 50% 
methanol) was performed for 20 minutes at 25°C.  The primary antibody cleaved-
caspase 3 (Cell Signaling Technology #9664, 1:100) was diluted in PBS 
containing 1% normal goat serum and 0.1% Triton X-100 and incubated on 
sections in a humidified chamber overnight at 4°C.  The antibody was visualized 
using the EnVision+ system-HRP (Dako # K4006) with the following 
modifications: the samples were incubated with the HRP-conjugated anti-rabbit 
secondary for 1 hour before being washed three times three minutes.  
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Localization of antibody staining was visualized by incubating the samples for 
five minutes in 37.5 µM DAB chromagen diluted in 1 mL of DAB substrate.  
Brightfield images were acquired on a Zeiss Axio Imager A1 equipped with an 
AxioCam MRc5 camera. 
Histology 	
 Decapitated embryos were fixed whole in 4% paraformaldehyde/2% 
glutaraldehyde.  Postnatal day 7 (P7) and adult small intestines were flushed with 
PBS after being cut into three equally sized segments (designated proximal, 
middle and distal), opened longitudinally, and fixed overnight with either 4% 
paraformaldehyde or with 10% neutral buffered formalin.  Whole embryos or 
Swiss-rolled intestinal tissues were paraffin-embedded and sectioned at 5µm.  
Hematoxylin and eosin staining was performed to assess tissue morphology. 	
 3.3 Results 
Intestinal organoids lacking ITCH have more viable, nonbudding organoid 
structures and less intricate growth patterns  
To investigate the epithelial-specific contribution of ITCH in the small 
intestine, 3-D enteroid cultures were established ex vivo from the intestinal crypts 
of 9-11 week old Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ animals.  After 
passaging these cultures a minimum of three times to mitigate the signaling 
contributions of the mesenchyme, the 3-D structures of the enteroid cultures 
were assessed using phase contrast microscopy.  This analysis revealed that 
ITCH deficient organoids, though viable, were not as intricate, and there seemed 
to be a greater number of nonbudding enteroids present in the Itcha18H/a18H; 
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Lgr5eGFP/+ culture as compared to the Itch+/+; Lgr5eGFP/+ culture (Fig.3.3.A).  To 
determine if this shift toward a nonbudding phenotype was statistically significant, 
the number of nonbudding organoids versus budding organoids was quantified 
from three independent isolates (independent culture preps) from each genotype.  
Out of a total of 184 ITCH sufficient and 199 ITCH deficient enteroids assessed, 
13 ITCH sufficient organoids versus 29 ITCH deficient organoids lacked buds 
(Fig. 3.3.B).  This difference was determined to be statistically significant using a 
chi-squared analysis with a 2x2 contingency table wherein the null hypothesis 
stated that no difference in the number of nonbudding versus budding organoids 
existed between the ITCH sufficient and ITCH deficient organoids (chi-square = 
5.519, df = 1, and p = 0.0188).   
Even though lack of ITCH compromised the initiation of crypt regeneration 
in enteroid culture, there were a considerable number of colonies lacking ITCH 
that did develop buds.  Since it is thought that the continued growth and 
expansion of crypts/buds is driven by crypt fission in organoids (Baker et al., 
2014), we sought to determine whether ITCH had any impact on this process.  
To that end, we reanalyzed the budding data after removing the counts for 
nonbudding colonies for each genotype.  This revealed that while Itch+/+; 
Lgr5eGFP/+-derived budding enteroids (n=167) displayed a median of 7 buds with 
an interquartile range (IQR) of 6, budding enteroids derived from Itcha18H/a18H; 
Lgr5eGFP/+  animals (n=160) had a median of 6 buds with an IQR of 5 (n=160), 
and this difference was statistically significant (p < 0.05) by Mann-Whitney U-test 
(Fig. 3.3.C).  This result suggested that ITCH may influence crypt fission to 
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promote branching of buds in organoid culture.  Thus, it would be predicted that 
organoids lacking ITCH should have less intricate, branching structures.  To test 
this hypothesis, organoid growth and morphology were qualitatively assessed in 
ITCH deficient and ITCH sufficient enteroids (n=2 independent isolates per 
genotype) using phase contrast microscopy at day 1, day 3, and day 5 after 
plating (Fig. 3.4).  The general trend that was noted was that at day 1 no budding 
was observed in cultures of either genotype, whereas at day 3 and day 5, buds 
were present and continuing to increase in number in both ITCH sufficient and 
deficient organoids.  However, when comparing the morphology of the organoids 
at day 5, the ITCH deficient cultures appeared more compact and less intricate 
with regards to branching as compared to the ITCH sufficient cultures (Fig 3.4.).  
Collectively, these data emphasize that while loss of ITCH does not impact the 
growth kinetics of the organoids, it does influence the intricacy of the budding 
structures of the organoids. 
Lack of ITCH does not grossly alter epithelial cell differentiation in enteroid 
culture  
 The subtleties in growth dynamics of those organoid cultures deficient for 
ITCH relative to those sufficient for ITCH prompted us to examine the Lgr5+ CBC 
stem cell population, which is known to promote the expansion of budding 
structures within enteroids (Sato et al., 2009).  Because, in our enteroid system, 
Lgr5-expressing intestinal stem cells are endogenously labeled with eGFP, green 
fluorescence can be utilized as a proxy to assess intestinal stem cell dynamics. 
However, only 17% of CBC stem cells are expected to be labeled because of the 
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mosaic nature of this construct (Dehmer et al., 2011).   This, coupled with the 
loss of organoids during processing, resulted in the examination of only 3 GFP+ 
organoids from two independent isolates of each genotype.  If these particular 
samples are viewed as representative of budding organoids at day 6, no 
difference in location of the eGFP signal, eGFP intensity, or number of eGFP+ 
cells was readily discernable within the budding structures of ITCH sufficient and 
ITCH deficient organoids (Fig. 3.5.A), though this certainly warrants further 
investigation.  
 Even though a robust cell intrinsic role for ITCH does not seem apparent 
in intestinal stem cells, global loss of ITCH in the small intestine does impact both 
intestinal epithelial progenitors as well as cell differentiation (Chapter 2).  Thus, 
we hypothesized that epithelial-specific loss of ITCH would result in similar 
defects observed in the Itcha18H/a18H animals, skewing cell specification toward the 
goblet and Paneth cell lineages.  To investigate this hypothesis, confocal 
fluorescence images coupled with phase-contrast microscopy were captured 
from day 6, Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ intestinal organoids 
immunostained for chromagranin A and lysozyme to identify enteroenocrine cells 
and Paneth cells, respectively.  Surprisingly, no gross difference in number of 
Paneth or enteroendocrine cells was detected in Itch deficient organoids 
compared to Itch sufficient organoids (Fig. 3.5.B).  To assess goblet cell 
differentiation, the distinctive cell shape of goblet cells was identified using 
phase-contrast microscopy revealing no marked defects in goblet cell 
differentiation between the two genotypes (Fig. 3.5.B).  Collectively, these data 
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demonstrate that loss of ITCH in organoid culture does not recapitulate the 
observed phenotype associated with global loss of ITCH in the Itcha18H/a18H 
animal, suggesting that the role of ITCH in epithelial cell specification is cell non-
autonomous and is likely influenced by ITCH deficient signals from other tissue 
types (most likely the immune system) in the small intestine in vivo. 
Itcha18H/a18H; Lgr5eGFP/+ intestinal organoids have increased apoptosis 
Despite not observing a change in intestinal homeostasis with regards to 
intestinal stem cell dynamics and cell fate specification within the ITCH deficient 
organoids, it is possible that ITCH may influence the integrity of the intestinal 
mucosal by regulating the turnover of the epithelium in the small intestine.  Within 
the Itcha18H/a18H small intestine, an increase in the proliferating progenitor 
population within the crypt leads to an acceleration of intestinal epithelial 
migration along the crypt-villus axis, thus, making it tempting to speculate that 
Itcha18H/a18H; Lgr5eGFP/+ intestinal organoids might display an increase in 
proliferation compared to Itch+/+; Lgr5eGFP/+ intestinal organoids.  To investigate 
this possibility, we assessed EdU incorporation from three replicates of whole 
mount intestinal organoids that were derived from 2 independent isolates of 
sufficient and deficient for ITCH.  Organoids plated for six days were pulsed with 
10 µM EdU for 1 hour before evaluating EdU incorporation by click chemistry.  
Upon the acquisition of fluorescent images captured by confocal microscopy, no 
difference in proliferation was observed between the two genotypes (Fig. 3.6.A).  
While the continued replacement of differentiated cells is an important 
component of intestinal cell turnover, proliferation must be balanced with the 
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extrusion of cells via the apoptotic process of anoikis in order to maintain 
intestinal epithelial function (J. M. Williams et al., 2015).  Since an increase in 
cleaved-caspase 3 staining was observed in the small intestine of young adult 
Itcha18H/a18H animals (Chapter 2), we hypothesized that lack of ITCH in just the 
intestinal epithelium would result in an increase in apoptosis.  Therefore, ITCH 
sufficient and ITCH deficient intestinal organoids were incubated with PI for 30 
minutes and then evaluated by epifluorescence microscopy.  Micrographs were 
taken from a minimum of eight 20x fields and the ratio of the surface area of the 
PI fluorescence to the total organoid surface area was measured from two age- 
and gender- matched isolates from each genotype using Image J.  Consistent 
with what was observed in whole animal studies, a significant increase (p<0.05) 
in percent surface area of PI staining was observed in the Itcha18H/a18H; Lgr5eGFP/+ 
intestinal organoids (30.9% ± 3.53%, SEM) compared to Itch+/+; Lgr5eGFP 
intestinal organoids (20.9% ± 2.42%, SEM) (Fig. 3.6.B).  This suggests a cell 
autonomous role for ITCH in intestinal epithelial apoptosis.   
To corroborate the results obtained from the intestinal organoid assay, 
apoptosis was also assessed in vivo using animals deficient for ITCH within the 
intestinal epithelium (Itchfl/fl; VillinCre/+).  For this analysis, cellular apoptosis was 
assessed by immunohistochemistry via the pro-apoptotic marker cleaved-
caspase 3.  Cleaved-caspase 3 staining was assessed from paraffin-embedded 
tissues that were derived from the distal small intestines of one Itchfl/fl; 
VillinCre/+and WT animal at 3 months of age.  Consistent with the ex vivo results, 
Itchfl/fl; VillinCre/+ animals had an increase in cleaved-caspase 3 staining, which 
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was most prevalent on the villi, compared to WT animals where a minimal 
amount of apoptosis was observed (Fig. 3.7).  Since global loss of ITCH results 
in altered differentiation programs on the villi (Chapter 2), images were acquired 
at a higher power magnification (63x) to determine if apoptosis in the small 
intestines from Itchfl/fl; VillinCre/+ animals was specific to enterocytes.  
Interestingly, cleaved caspase 3 staining was observed in both enterocytes and 
goblet cells present on the villi (Fig. 3.7), emphasizing that ITCH’s role in 
apoptosis is not cell type specific, but seems to act in differentiated cells of both 
the absorptive and secretory lineages.  
Myeloid-derived cells lacking ITCH influence epithelial cell specification within the 
small intestine in a time dependent manner 
 Contrary to the described role for ITCH we observed in intestinal epithelial 
homeostasis in vivo, no difference in cell proliferation (Fig. 3.6.A) or specification 
(Fig. 3.5.B) was observed between ITCH sufficient and deficient organoids.  
Further support for this phenotype is evidenced from histological evaluation of 
Itchfl/fl; VillinCre/+ and WT small intestines.  In particular, no marked deviation in 
cell type specification (i.e., comparable numbers of goblet and Paneth cells), as 
well as crypt and villus size were present in Itchfl/fl; VillinCre/+ intestines when 
compared to the WT controls histologically at 2 months of age (Fig. 3.7).  Thus, 
the global loss of ITCH function phenotype likely results from the combined 
actions of cell types outside of just the epithelium.  The most likely suspect for 
non-cell autonomous function of ITCH influencing epithelial homeostasis would 
be the immune system due to its immunosurveillance function within the small 
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intestine.  Recently, ITCH was determined to attenuate NOD2:RIP2 induced 
NFκB signaling in primary macrophages derived from Itcha18H/a18H animals (M. F. 
Tao et al., 2009).  Thus, in combination with the presence of neutrophils (Ramon 
et al., 2011) and eosinophils (Ramon et al., 2011) within the lamina propria of the 
small intestine in 5-6 month old Itcha18H/a18H animals, we hypothesized that loss of 
ITCH within the myeloid cell lineage could contribute to the altered epithelial 
homeostasis in the small intestine.  
 To analyze the contribution of ITCH in the innate immune system, animals 
lacking ITCH within the myeloid cell lineage (Itchfl/fl; LysMCre/Cre) , Itcha18H/a18H and 
WT animals were compared at 2 and 6 months of age.  Formalin-fixed, paraffin-
embedded sections dervived from all three genotypes were stained with H&E to 
assess tissue morphology (Fig. 3.8).  At two months of age, the Itchfl/fl; 
LysMCre/Cre-derived small intestines looked comparable to the small intestines of 
the WT controls.  However, this was in stark contrast to the small intestines from 
Itcha18H/a18H animals, which displayed signs of crypt hyperplasia that was 
accompanied by an increase in goblet and Paneth cells.  Interestingly, the 
intestine from 6-month-old Itchfl/fl; LysMCre/Cre animals more closely resembled the 
intestines of the Itcha18H/a18H at 2 months of age in that crypt area was increased, 
as well as goblet and Paneth cell numbers.  Furthermore, the Itcha18H/a18H 
intestines from 6-month-old animals appeared progressively worse with regards 
to goblet cell differentiation.  Collectively, these data highlight the fact that loss of 
ITCH in the small intestine, whether ubiquitous or myeloid-specific, drives a 
progressive shift in epithelial homeostasis. 
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3.4 Discussion  
Here, we have delineated epithelial- and myeloid-specific roles for ITCH 
that collectively contribute to the preservation of adult intestinal epithelial 
homeostasis and mucosal function by regulating crypt formation, cellular 
differentiation, and apoptosis.  When mature intestinal organoids sufficient and 
deficient for ITCH were established, loss of ITCH had no impact on temporal 
cell growth (Fig. 3.4), proliferation (Fig. 3.6.A), or cell fate specification (Fig. 
3.5.B).  However, an increase in apoptosis was observed in ITCH deficient 
organoids compared to ITCH sufficient organoids (Fig. 3.6.B), which was 
further substantiated by an increase in cleaved-caspase 3 staining within the 
small intestine of Itchfl/fl ; VillinCre/+ animals (Fig. 3.7). Among ITCH’s numerous 
substrates, c-FLIP, the p53 family members, p63 and p73, LATS1, and TXNIP, 
have been implicated in cell apoptosis (Aki et al., 2015).  With the exception of 
the anti-apoptotic protein c-FLIP, loss of ITCH stabilizes these protein 
substrates to promote apoptosis.  Thus, we anticipate that Itcha18H/a18H and 
Itchfl/fl; VillinCre/+ would have increased expression in one or more of these pro-
apoptotic targets.  With the limited expression of p73 in the small intestine, and 
complete absence of p63, the likelihood of this family that one of these 
proteins is driving the observed apoptosis in the small intestine.  In contrast, 
the tumor suppressor, LATS1 (Ho et al., 2011), and the cellular redox inhibitor, 
TXNIP (Zhang et al., 2010) are both expressed in the small intestine, offering a 
potentially mechanism by which cell demise could be mediated in both ITCH 
deficient organoids as well as Itchfl/fl; LysMCre/Cre animals.  
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 In the highly proliferative small intestine, the Lgr5+ CBC stem cell 
population is a critical driver of self-renewal.  There is mounting evidence to 
support a cell-autonomous contribution for ITCH in the cellular dynamics of 
embryonic (ESC) and hematopoietic (HSC) stem cells.  Specifically, ITCH has 
been shown to downregulate the transcription factor OCT4 in ESCs, 
compromising ESC renewal capacity as well as somatic cell reprogramming 
(Liao et al., 2013).  Furthermore, ITCH deficient HSCs were shown to have a 
hyperproliferative phenotype, which was attributed to accelerated cell cycle entry, 
as compared to ITCH sufficient HSCs (Rathinam et al., 2011).  When intestinal 
organoids deficient for ITCH were cultured, a significant decrease in the average 
number of buds per organoid was observed in Itcha18H/a18H; Lgr5eGFP/+ organoids 
versus Itch+/+ ; Lgr5eGFP/+ organoids (Fig. 3.3.A), suggesting that a cell-
autonomous role for ITCH in the epithelium likely influences the stem cell niche. 
Though a decrease in the average number of buds in mature ITCH deficient 
organoids was noted, a reduction in eGFP-labeled Lgr5+ intestinal stem cells was 
not readily apparent, indicating that a depletion of the rapidly cycling stem cell 
population is not necessarily the driving factor of this phenotype.  However, due 
to the mosaic nature of this construct (Dehmer et al., 2011) and the limited 
number of samples assessed, a decrease in Lgr5+ stem cells within ITCH 
deficient organoids still remains a formal possibility.  Due to the similarities in 
EdU incorporation between the ITCH sufficient and ITCH deficient organoid 
cultures, it seems unlikely that a decrease in proliferation underlies the observed 
decrease in average budding number associated with ITCH deficiency.  
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Alternatively, p53-independent spontaneous apoptosis of epithelial cells within 
the crypts of the small intestine has been suggested to influence homeostatic 
stem cell dynamics (Renehan et al., 2001), and provides a potential mechanistic 
link between increased epithelial cell apoptosis associated with loss of ITCH and 
the defects observed in crypt fission within mature, budding ITCH deficient 
organoids.  
 While loss of ITCH alters crypt fission in mature, budding intestinal 
organoids, an additional role for ITCH upstream of this process is suggested by 
the significant expansion of the nonbudding population in the Itcha18H/a18H; 
Lgr5eGFP/+  organoid cultures as compared to Itch+/+; Lgr5eGFP/+ organoid cultures 
(Fig 3.3.B).  Interestingly, the nonbudding Itcha18H/a18H; Lgr5eGFP/+  organoids did 
not adopt a hyperproliferative, cyst-like phenotype that typically appears either 
with organoids disrupted for APC (Germann et al., 2014) or those with 
constitutive β-catenin signaling (T. Sato and Clevers, 2013), minimizing the 
possibility that an expansion in stem and/or progenitor cell populations, at the 
expense of differentiation, is the impetus behind this phenotype.  A failure to bud 
in the ITCH deficient organoids could result from improperly integrating signals 
necessary for the initiation budding.  Normally the Lgr5+ stem cell population and 
the surrounding WNT-producing Paneth cells propel themselves outward, likely 
mediated by the repulsive force established from the EphB-EphrinB gradient 
along the budding structure (Toshiro Sato and Clevers, 2013), similar to what has 
been described in vivo (Batlle et al., 2002b).  Establishment of the EphB-EphrinB 
gradient is dependent on β-catenin and TCF, a transcription factor that mediates 
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canonical WNT signaling (Fig. 3.1) (Batlle et al., 2002b).  In the small intestine of 
Itcha18H/a18H animals, we observed a decrease in β-catenin levels within the crypt 
of the small intestine (Fig.3.9).  Thus, we speculate that a decrease in β-catenin 
within the budding structure of the organoid could disrupt the gradients of WNT 
and EphB-EphrinB to compromise bud initiation.  While defects in bud initiation 
and budding numbers are observed ex vivo in Itcha18H/a18H; Lgr5eGFP/+ organoids, 
accelerated crypt formation is observed in Itcha18H/a18H intestines at E18.5 and P7 
(Fig. 3.10), suggesting loss of ITCH function in additional cell types could 
influence crypt development.  Thus, identifying the molecular signatures 
associated with loss of ITCH within the crypts of Itcha18H/a18H animals and budding 
defects in ITCH deficient organoids will provide insight into the contribution of 
ITCH to mucosal homeostasis.  
 The failure of ITCH deficient intestinal organoids and Itchfl/fl ; VillinCre/+ 
animals to completely recapitulate the altered intestinal epithelial phenotype in 
Itcha18H/a18H animals emphasizes the contribution of ITCH within the immune 
compartment of mucosa.  Support for this crosstalk between the immune system 
and epithelium is derived from the comparable intestinal phenotype between 6-
month-old Itchfl/fl; LysMCre/Cre and Itcha18H/a18H animals at 2 months of age (Figure 
3.8).  Within the innate immune system, ITCH influences the proinflammatory 
response of macrophages by regulating NOD2-dependent NFκB (M. F. Tao et 
al., 2009).  We anticipate that the macrophage population within the lamina 
propria drives alterations in intestinal epithelial homeostasis within the small 
intestine of Itchfl/fl; LysMCre/Cre animals.  Interestingly, tissue-resident intestinal 
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macrophages are highly tolerogenic of the external environment and are capable 
of employing a variety of mechanisms that effectively clear pathogens while 
tempering the immunological response (Bain and Mowat, 2014).  Thus, it is 
tempting to speculate that ITCH deficient macrophages within the small intestine 
generate an inappropriate immunological response to the local environment, 
which likely promotes intestinal inflammation and altered epithelial homeostasis.  
 While a novel myeloid-specific role for ITCH in intestinal epithelial 
homeostasis is highlighted by an expansion in crypt area, and goblet and Paneth 
cell hyperplasia, a delay in the presentation of the phenotype in Itchfl/fl; LysMCre/Cre 
compared to Itcha18H/a18H animals emphasizes the multifaceted role ITCH plays in 
the integration of intestinal mucosal functionality and integrity.  Thus, it is 
tempting to speculate that an increase in apoptosis associated with loss of ITCH 
in the epithelium could contribute to the inflammatory response by allowing 
bacteria to more easily interact with the immune compartment.  Since apoptosis 
of intact intestinal epithelium alone does not increase intestinal inflammation 
(Hausmann, 2010), the altered inflammatory response in ITCH deficient immune 
cells, both within the myeloid and lymphoid compartments, is likely required to 
drive the altered intestinal epithelial phenotype.  However, a formal possibility 
remains wherein additional tissue types, such as surrounding mesenchyme, 
could influence intestinal homeostasis.  Thus, the continued examination of the 
tissue-specific functions for ITCH as well as the synergistic roles of ITCH within 
the epithelium and the immune system in the intestinal mucosa is vital to 
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identifying novel therapeutic avenues to explore in the treatment of mucosal 
enteropathies.  
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3.5 Figures  
 
Figure 3.1.  EphrinB-EphB gradients within the crypt of the small intestine.  
Interactions between EpherinB ligands and EphB receptors influence cellualer 
spatial localization and migration within the crypt.  Both WNT and EphrinB 
ligands within the intestinal epithelium establishes the location and migration of 
epithelial cells along the crypt-villus axis.  The absence of EphrinB ligands in the 
crypt, despite the presence of the EphB recpetors, anchors both CBC stem cells 
and Paneth cells to the base of the crypt.  Adapted from (Scoville et al., 2008). 
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Figure 3.2.  Generation of Itchfl/fl; LysMCre/Cre animals. (A)  Itchfl/fl aniamls were 
generated by placing flanked LoxP cite into intron 5 and intron 7 of the Itch locus. 
(B) Breeding scheme employed to generate Itchfl/fl; LysMCre/Cre animals.  Due to 




Figure 3.3.  Itch deficient intestinal organoids have alterations in budding 
initiation and budding fission.  (A) Representative phase contrast images of 
Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ intestinal organoids at day 5 
following plating highlights an increase in the number of nonbudding organoids 
in Itch deficient organoids compared to Itch sufficient organoids.  Scale bars = 
200 µm.  (B) Graphical representation of a chi-squared analysis of a 2x2 
contingency table (chi-square=5.519, df=1) demonstrating a statistically 
significant difference (p =0.0188) in the number of nonbudding versus budding 
organoids between Itch+/+; Lgr5eGFP/+ (n=184) and Itcha18H/a18H; Lgr5eGFP/+ 
(n=199).  Organoids were counted from 3 independent wells per Itch+/+; 
Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ intestinal crypt isolate. Data represents a 
total of 3 isolates per genotype.  (C) A significant reduction (*p<0.05) in the 
average number of buds per intestinal organoid was observed when comparing 
only budding structures in Itch+/+; Lgr5eGFP/+ (n=167, median = 7, IQR = 6) to 
Itcha18H/a18H; Lgr5eGFP/+ (n=162, median = 6, IQR = 5) derived enteroids at day 5. 
Organoids were counted from 3 independent wells per Itch+/+; Lgr5eGFP/+ and 





3.4.  Loss of ITCH results in more compact and less intricate organoids.  
Representative phase contrast images of Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; 
Lgr5eGFP/+ intestinal organoids at day 1, day 3, and day 5.  No difference in 
growth kinetics was observed between mature Itch sufficient and Itch deficient 





Figure 3.5.  Itch deficient organoids are capable of producing differentiated 
cell types from Lgr5eGFP/+ stem cells.  (A) Confocal fluorescent imaging of 
endogenous eGFP expression of whole-mount Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H 
; Lgr5eGFP/+ intestinal organoids fixed in 4% PFA and co-stainined with DAPI.  
ITCH deficiency does not appear to impact the number or location of intestinal 
Lgr5eGFP+ stem cells within the budding structures of the intestinal organoids 
when compared to ITCH sufficient organoids.  Scale bar = 50µm.  (B) Confocal 
fluorescent-phase contrast images of 4% PFA-fixed, frozen sections stained with 
anti-chromagranin A (enteroendocrine cell marker) or anti-lysozyme (Paneth cell 
marker).  Goblet cells were identified by cell morphology using phase-contrast 
microscopy.  No difference was observed in ITCH deficienct organoids compared 
to ITCH sufficient organoids, suggesting that loss of ITCH in the intestinal 
epithelium does not markedly impact epithelial cell differentation.  Scale bar = 50 





Figure 3.6.  Loss of ITCH in intestinal organoids impacts cell apoptosis in 
budding organoids.  (A) Confocal fluorescent imaging of EdU incorporation 
within proliferating cells from whole-mount Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; 
Lgr5eGFP/+ intestinal organoids fixed in 4% PFA and co-stainined with DAPI.  
ITCH deficiency does not appear to impact cell proliferation when compared to 
ITCH sufficient organoids.  Scale bar = 100 µm.  (B) Epifluorescent-phase 
contrast images of whole mount Itch+/+ ; Lgr5eGFP/+ and Itcha18H/a18H ; Lgr5eGFP/+ 
intestinal organoids stained with propridium iodide (PI).  A 10% statisctically 
significant increase (*p<0.05) in the surface area of PI fluorescence is observed 
in Itcha18H/a18H ; Lgr5eGFP/+ intestinal organoids (n=84) compared to Itch+/+; 
Lgr5eGFP/+ (n=94).  Organoids were counted from 2 independent wells per Itch+/+; 
Lgr5eGFP/+ and Itcha18H/a18H;Lgr5eGFP/+ intestinal crypt isolate.  Data represents a 
total of 2 isolates per genotype.  Scale bar = 100 µm.  Error bars represent SEM. 
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Figure 3.7.  Epithelial specific loss of ITCH  in the small 
intestine promotes epithelial apoptosis.  Paraffin-embedded 
sections from the distal small intestine of 3 month old WT and 
Itchfl/fl ; VillinCre/+ animals immunostained for cleaved-caspase 3 
and counterstained with hematoxylin.  Animals lacking ITCH in 
the intestinal epithelium have increased apoptosis on the villi of 
the small intestine compared to WT controls.  Higher power 
magnification (bottom) highlights apoptotic goblet (*) and 
enterocytes (arrows), indicating that apoptosis is not cell-type 
dependent.  Scale bars = 100 µm (top) and 50 µm (bottom).
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Figure 3.8.  Loss of ITCH in the myeloid lineage leads to late-onset 
alterations in intestinal epithelial morphology that is similar to 
Itcha18H/a18H  at 2 months.  H&E paraffin-embedded sections from the distal 
small intestine of 2 month and 6 month old WT, Itchfl/fl; LysMCre/Cre , and 
Itcha18H/a18H animals.  At 2 months, no histological abnormalities are 
observed in the epithelium of the small intestine from Itchfl/fl; LysMCre/Cre 
animals.  By 6 months, the intestinal epithelium from Itchfl/fl; LysMCre/Cre 
looks similar to Itcha18H/a18H animals at 2 months of age with an expanded 
crypt compartment and increased goblet and Paneth cell numbers 
suggesting that loss of ITCH in the myeloid cell lineage contributes to the 
epithelial alterations observed in the small intestine of Itcha18H/a18H animals.  
However, a delay in the presentation of altered intestinal morphology 
suggests that loss of ITCH in additional tissue types (i.e., epithelium) likely 
accelerates the epithelial defects that are observed in Itcha18H/a18H animals at 





Figure 3.9.  β-catenin expression is reduced in 
Itcha18H/a18H animals.  Paraffin-embedded sections from 
the distal small intestine of young adult Itch+/+ and 
Itcha18H/a18H animals immunostained for β-catenin and 
counterstained with hematoxylin.  Animals lacking ITCH in 
the intestinal epithelium have reduced levels of β-catenin 
at the membrane of cells in the crypt of the small intestine 
compared to WT controls.  Scale bars = 50µm.   
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Figure 3.10.  Loss of ITCH accelerates epithelial maturation during 
development.  (A) Representative H&E stained paraffin-embedded small 
intestinal sections from E18.5 (left) and P7 (right) Itch+/+ and Itcha18H/a18H 
animals show precocious crypt emergence in the Itcha18H/a18H animals.  Black 
dashed lines in the insets outline crypt borders.  Scale bars = 200 µm.  Original 
magnification of insets = 63x.  (B) Intracellular vacuoles (arrows) located within 
distal enterocytes from P7 Itch+/+ and Itcha18H/a18H animals highlight a difference 
in the apical canalicular system in the Itcha18H/a18H animals, consistent with 




 The small intestine is a highly dynamic tissue that plays a vital role in 
digestion, nutrient absorption, and water balance while simultaneously preventing 
the entry of foreign substrates (Bischoff et al., 2014).  The mucosal barrier is an 
integral component of this process, effectively separating the external 
environment from the body's internal milieu.  Preservation of the mucosal barrier 
is, in part, established by the concerted effort between the epithelium and the 
immune system (Rescigno, 2011.)  Bacteria that colonize the small intestine are 
constantly challenging the efficacy of the barrier.  The epithelium that lines the 
luminal cavity provides an initial physical barrier that prevents the passage of 
bacteria into the internal compartment of the host.  While this mainstay barrier is 
typically an effective deterrent, the constant exposure of noxious substances, 
antigens, and microorganisms to the surface of the epithelium makes a breach in 
foreign material eventually inevitable (Schenk and Mueller, 2008).  In this event, 
resident intestinal macrophages and dendritic cells that encounter the bacteria 
will cytotoxically destroy the bacteria without initiating an inflammatory response, 
which preserves the architecture and function of the epithelium (intestinal 
epithelial homeostasis).  However, if the innate immune cells fail to remain 
tolerogenic, an inappropriate inflammatory response is generated which can lead 
to epithelial destruction and compromised small intestinal function. 
	 113	
 Here we present evidence of both cell autonomous and non-cell 
autonomous roles for the ubiquitin ligase ITCH in epithelial homeostasis in the 
small intestine.  Increased cell death was noted in both ITCH deficient 
organoids and in Itchfl/fl; VillinCre/+ animals, supportive of an epithelial-specific 
function for ITCH in cell demise.  As previously discussed, increased ITCH-
mediated epithelial apoptosis could be driven by the disorganization of 
adherens junctions (Chapter 1) or by the increased expression of the ITCH-
targeted substrates LATS1 or TXNIP (Chapter 3).  However, an additional role 
for ITCH in the regulation of apoptosis, most likely associated with 
inappropriate activation of the immune system, is emphasized by a shift in 
apoptotic cells from the villus of Itchfl/fl; VillinCre/+ animals towards the upper 
region of the crypt in the Itcha18H/a18H small intestine.  TNF-α, a pro-
inflammatory cytokine that is produced by both innate and acquired immune 
responses, enhances epithelial apoptosis in the intestine (Nunes et al., 2014; 
Watson and Hughes, 2012).  We anticipate that the aberrant activation of the 
immune system within the gastrointestinal tract of the Itcha18H/a18H animal will 
promote TNF-α mediated apoptosis, and, in combination with ITCH’s cell 
autonomous role in epithelial apoptosis, increased stress is placed on the 
epithelium to initiate apoptosis at an earlier point in the epithelial turnover 
process.  Alternatively, cell death within the crypt has been suggested as a 
homeostatic mechanism to control the number of terminally differentiated cells 
that will migrate onto the villus by controlling the number of progenitor cells 
within the crypt (Hall et al., 1994).  The prevalence of apoptotic cells in the 
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upper crypt of Itcha18H/a18H animals may represent an attempt to limit the 
number of transit-amplifying cells to maintain homeostasis. 
 It is interesting to note that additional signaling pathways within the 
epithelium, such as NFκB, can influence the outcome of TNF-α mediated 
apoptosis (Chang et al., 2006; Wullaert et al., 2011).  Active NFκB signaling in 
the intestinal epithelium is protective against TNF-α mediated apoptosis, and the 
absence of NFκB signaling in the presence of this cytokine promotes cell death.  
(Wullaert et al., 2011).  Accumulating evidence supports that ITCH is a negative 
regulator of NFκB signaling (Chang et al., 2006; Shembade et al., 2008; M. Tao 
et al., 2009).  We anticipate that loss of ITCH function promotes NFκB signaling 
in the epithelium, which could protect the epithelium from TNF-α induced 
apoptosis.  Thus, loss of ITCH in the epithelium in the presence of inflammation 
might serve as a protective mechanism to counteract inflammation-driven 
apoptosis in an attempt to preserve barrier function.   
The fact that the epithelial-specific loss of ITCH fails to recapitulate the 
small intestinal epithelial phenotype in the ubiquitous loss of function ITCH 
animals suggests that ITCH plays an important role in immune tissue to 
contribute to epithelial homeostasis.  Loss of ITCH function in the myeloid cell 
compartment of 6-month-old animals resulted in crypt hyperplasia as well as 
increased specification toward goblet and Paneth cells, similar to the young 
adult Itcha18H/a18H small intestinal phenotype.  Evidence supports a cell 
autonomous function for ITCH in macrophages to fine tune the 
proinflammatory response in macrophages by modulating NFκB signaling (M. 
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Tao et al., 2009).  To prevent an inappropriate response to the luminal 
bacteria, macrophages in the small intestine are tolerogenic and do not induce 
pro-inflammatory cytokines in the presence of antigenic substrates (Gross et 
al., 2015).  Due to the aberrant activation of the immune system in the 
absence of a known pathogen in Itcha18H/a18H animals, we suspect ITCH 
deficient macrophages are less tolerogenic and initiate an NFκB-dependent, 
pro-inflammatory response that influences epithelial homeostasis.  
Additionally, the heightened immune response of ITCH deficient macrophages 
likely activates effector T cells, which, in turn, will feed back onto the 
epithelium to further influence tissue homeostasis.  Consistent with assertion, 
the delayed development of an epithelial phenotype in Itchfl/fl; LysMCre/Cre 
animals as compared to Itcha18H/a18H animals supports that additional tissue 
types contribute to the shift in epithelial homeostasis.  While the epithelium is a 
likely contributor to this phenotype (Chapter 2 Discussion), loss of ITCH in 
lymphoid tissues might contribute as well, which is evidenced by the lack of 
epithelial disarray that is observed in Itcha18H/a18H animals on a Rag1-/- 
background as compared to Itcha18H/a18H animals. 
 The inability of the tissue-specific losses of ITCH in either the epithelium 
or in the immune system to recapitulate the global loss of ITCH phenotype 
characterized by increased cell proliferation and apoptosis within the crypt, 
enhanced terminal differentiation of goblet and Paneth cells, and accelerated cell 
migration along the crypt-villus axis, suggests that loss of ITCH in both epithelial 
and immune tissues contributes to this phenotype.  We hypothesize the loss of 
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ITCH in the epithelium enhances apoptosis, which promotes the translocation of 
commensal bacteria into the host more readily.  The presence of bacteria in the 
lamina propria prompts a response from the resident innate immune cells.  
However, due to loss of ITCH function in this tissue as well, this likely decreases 
the tolerance of the innate immune cells to the bacteria and leads to a 
heightened inflammatory response, which feeds back onto the epithelium and 
influences homeostasis.  Because the epithelium response by increasing 
migration, as well as goblet and Paneth cell differentiation, which are considered 
protective measures against pathogen invasion.  This shift in epithelial 
homeostasis attempts to minimize further bacteria invasion and epithelial 
destruction.  Similar to NFκB signaling in the small intestine, we propose that 
ITCH has dual functions in regulating small intestinal mucosal homeostasis that 
is context-dependent.  Further elucidation of how ITCH influences mucosal 
homeostasis in the epithelium and the immune system, as well as the cross-talk 
between this two tissue types, will provide insight how ITCH impacts a range of 
gastrointestinal enteropathies, including inflammatory bowel diseases, celiac 
disease, and cancer.  
Interestingly, our data support that loss of ITCH is protective in sporadic 
colorectal cancer.  With the numerous tumor suppressor targets that are 
substrates for ITCH, it is not surprising that ITCH expression is robustly 
increased in intestinal adenocarcinomas (Uhlen, 2005).  While we have proposed 
that loss of ITCH function in ApcMin/+ tumorigenesis significantly reduces tumor 
burden by driving cells toward a differentiated state and leads to a reduction in 
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anchorage dependent growth of transformed cells (Chapter 2), it is tempting the 
speculate that apoptosis contributes as well.  We anticipate that loss of ITCH 
would enhance apoptosis in ApcMin/+ small intestinal adenomas.  Alternatively, the 
altered inflammatory state that is present in the small intestine of the Itcha18H/a18H 
animals could also contribute to decreased tumor burden.  In colorectal cancer, 
the activation of the immune system establishes a pro-inflammatory environment 
which promotes tumor growth (Ellyard et al., 2007).  Thus, we anticipate that loss 
of ITCH function either does not produce a pro-inflammatory environment or the 
immune system’s response is modified.  γδ T-cells are subset of specialized T-
cells that primarily localize to the lamina propria of the intestine and contribute to 
innate immunity by destroying epithelial cells that have been invaded or 
damaged by pathogenic material as well as by producing multifunctional memory 
T-cells that rapidly response if re-exposure occurs (Sheridan et al., 2013; van 
Wijk and Cheroutre, 2010).  In Itcha18H/a18H animals, elevated levels of serum IgE, 
an immunoglobulin that promotes allergic reactions, is secreted by the γδ T cell 
population (Parravicini et al., 2008).  However, accumulating evidence also 
suggests a role for IgE in anti-tumor immunity (Leoh et al., 2015).  Thus, it is 
tempting to speculate that loss if ITCH promotes antibody-dependent cell-
mediated cytotoxicity toward intestinal adenomas by generating IgEs targeted 
against a tumor-associated antigen.  Further, the aberrant activation of the 
immune system in ITCH deficient animals may provide a more robust 
inflammatory response to effectively destroy the tumor.  IgE induces a robust 
inflammatory response by recruiting key effector mediator cells, such as 
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eosinophils, basophils, and mast cells, to destroy the target.  The increased 
presence of eosinophils is a hallmark of the IgE inflammatory response, and the 
degranulation of these cells contributes to cytotoxic destruction of their targets 
(Leoh et al., 2015).  In 5-month-old Itcha18H/a18H animals, an increased number of 
eosinophils are present in the small intestine (Ramon et al., 2011), potentially 
providing support for IgE-mediated destruction of ApcMin/+ intestinal adenomas. 
The activation of the host’s immune system has proven extremely 
effective in the adjuvant treatment of cancer.  Since 2013, the FDA has approved 
15 monoclonal immunotherapies for the treatment of cancer (Farkona et al., 
2016).  The potential ability of ITCH deficient γδ T-cells to secrete IgE antibodies 
targeted against tumor-specific antigens could be of therapeutic interest in the 
treatment of colorectal cancer.  While passive immunotherapy has proven 
extremely effective, endogenous activation of the immune system to induce 
immunoglobulins that are specifically directed at tumor-associated antigens will 
provide a more personalized approach in the treatment of colorectal cancer.  
Furthermore, the endogenous activation of the immune system will likely 
generate memory effectors cells that can induce a more rapid immune response 
if subsequent exposure occurs.  Thus, the continued examination of ITCH in 
epithelial and immune tissues in the intestine, as well as how these tissue 
interact to maintain mucosal homeostasis, will likely identify novel therapeutic 
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